Shoji Fukushima
#124,042
Most Influential Person Now
Researcher
Shoji Fukushima's AcademicInfluence.com Rankings
Shoji Fukushimacomputer-science Degrees
Computer Science
#5124
World Rank
#5414
Historical Rank
Computational Linguistics
#640
World Rank
#652
Historical Rank
Machine Learning
#1241
World Rank
#1261
Historical Rank
Artificial Intelligence
#1468
World Rank
#1497
Historical Rank
Download Badge
Computer Science
Shoji Fukushima's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science Kyoto University
- Bachelors Computer Science Kyoto University
Similar Degrees You Can Earn
Why Is Shoji Fukushima Influential?
(Suggest an Edit or Addition)Shoji Fukushima's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Some drinking-water disinfectants and contaminants, including arsenic. (2004) (889)
- Carcinogenicity of butylated hydroxyanisole in F344 rats. (1983) (654)
- Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis. (1986) (532)
- Carcinogenicity and modification of the carcinogenic response by BHA, BHT, and other antioxidants. (1985) (319)
- Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats. (1983) (296)
- Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. (1995) (257)
- Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. (2002) (217)
- Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. (1999) (191)
- Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. (2007) (186)
- HISTOPATHOLOGICAL ANALYSIS OF PRENEOPLASTIC CHANGES DURING N‐BUTYL‐N‐(4‐HYDROXYBUTYL)‐ NITROSAMINE‐INDUCED URINARY BLADDER CARCINOGENESIS IN RATS (1982) (182)
- Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. (1983) (169)
- Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats (2015) (158)
- High frequency of K-ras mutations in human colorectal hyperplastic polyps. (1997) (157)
- GRAS flavoring substances 25 (2001) (145)
- Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. (1996) (140)
- Chemopreventive Potential of Volatile Oil From Black Cumin (Nigella sativa L.) Seeds Against Rat Colon Carcinogenesis (2003) (139)
- Cancer prevention by organosulfur compounds from garlic and onion (1997) (131)
- Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma (1989) (129)
- Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC). (2003) (127)
- Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers (2004) (124)
- Roles of urinary sodium ion concentration and pH in promotion by ascorbic acid of urinary bladder carcinogenesis in rats. (1986) (121)
- Carcinogenic activity of quinoline on rat liver. (1976) (119)
- Enhancing effects of diallyl sulfide on hepatocarcinogenesis and inhibitory actions of the related diallyl disulfide on colon and renal carcinogenesis in rats. (1992) (115)
- Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. (1995) (112)
- Prognostic significance of the MIB‐1 proliferation index for patients with squamous cell carcinoma of the esophagus (1995) (107)
- IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. (2015) (107)
- Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity. (2008) (106)
- Genotoxicity and Cytotoxicity of Multi‐wall Carbon Nanotubes in Cultured Chinese Hamster Lung Cells in Comparison with Chrysotile A Fibers (2010) (104)
- Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine. (1984) (104)
- Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens. (2005) (98)
- IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs). (2015) (96)
- Formation of 8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation of oxidative stress by phenobarbital: association with expression profiles of p21(WAF1/Cip1), cyclin D1 and Ogg1. (2002) (95)
- Uracil-induced urolithiasis and the development of reversible papillomatosis in the urinary bladder of F344 rats. (1986) (94)
- Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine. (1983) (90)
- Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats. (1986) (90)
- Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. (2010) (86)
- Value of GST-P Positive Preneoplastic Hepatic Foci in Dose-Response Studies of Hepatocarcinogenesis: Evidence for Practical Thresholds with Both Genotoxic and Nongenotoxic Carcinogens. A Review of Recent Work (2003) (84)
- Understanding arsenic carcinogenicity by the use of animal models. (2004) (83)
- Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model. (1991) (82)
- Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S‐transferase placental form positive foci: A possible reactive oxygen species mechanism (2002) (80)
- Effects of butylated hydroxyanisole, butylated hydroxytoluene, and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats. (1984) (80)
- Promotion of urinary bladder carcinogenesis in experimental animals. (1989) (79)
- Induction of prostate carcinoma in situ at high incidence in F344 rats by a combination of 3,2'-dimethyl-4-aminobiphenyl and ethinyl estradiol. (1986) (79)
- High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele. (1998) (78)
- Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression. (2003) (78)
- Promotion of Rat Hepatocarcinogenesis by Dimethylarsinic Acid: Association with Elevated Ornithine Decarboxylase Activity and Formation of 8‐Hydroxydeoxyguanosine in the Liver (1997) (77)
- Pulmonary toxicity of intratracheally instilled multiwall carbon nanotubes in male Fischer 344 rats. (2010) (75)
- Thirteen-week study of toxicity of fiber-like multi-walled carbon nanotubes with whole-body inhalation exposure in rats (2015) (75)
- Inhalation Carcinogenicity and Chronic Toxicity of Indium‐tin Oxide in Rats and Mice (2011) (75)
- Urinary excretion of arsenic metabolites after long-term oral administration of various arsenic compounds to rats. (1998) (75)
- Organ-specific promoting effect of phenobarbital and saccharin in induction of thyroid, liver, and urinary bladder tumors in rats after initiation with N-nitrosomethylurea. (1983) (74)
- Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats. (1984) (73)
- Induction of squamous cell carcinoma in the forestomach of F344 rats treated with butylated hydroxyanisole. (1982) (72)
- Lack of Carcinogenicity of Quercetin in F344/DuCrj Rats (1989) (71)
- Lack of a Dose‐response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline or N‐Nitrosodiethylamine (2002) (71)
- Reversible papillary hyperplasia of the rat urinary bladder. (1978) (66)
- Sequential changes of the forestomach of F344 rats, Syrian golden hamsters, and B6C3F1 mice treated with butylated hydroxyanisole. (1986) (65)
- Stomach Carcinogenicity of Caffeic Acid, Sesamol and Catechol in Rats and Mice (1990) (64)
- Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses. (1991) (63)
- Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice. (2003) (62)
- Protective effects of some neutral amino acids against hypotonic hemolysis. (1995) (62)
- Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features (1997) (62)
- Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation. (1997) (62)
- Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer (2017) (62)
- Promoting effect of sodium o-phenylphenate and o-phenylphenol on two-stage urinary bladder carcinogenesis in rats. (1983) (61)
- Modification of N-methyl-N'-nitro-N-nitrosoguanidine-induced forestomach and glandular stomach carcinogenesis by phenolic antioxidants in rats. (1988) (60)
- Effects of three sweeteners on rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine. (1984) (60)
- Differences in susceptibility to sodium saccharin among various strains of rats and other animal species. (1983) (60)
- Enhancement by organosulfur compounds from garlic and onions of diethylnitrosamine-induced glutathione S-transferase positive foci in the rat liver. (1994) (59)
- Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat. (1983) (58)
- Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis (2008) (58)
- Arsenic exposure and its health effects and risk of cancer in developing countries: micronutrients as host defence. (2007) (58)
- Cell proliferation induced by uracil-calculi and subsequent development of reversible papillomatosis in the rat urinary bladder. (1989) (58)
- Carcinogenicity studies of 1,4-dioxane administered in drinking-water to rats and mice for 2 years. (2009) (58)
- Changes in urine composition, bladder epithelial morphology, and DNA synthesis in male F344 rats in response to ingestion of bladder tumor promoters. (1989) (57)
- Modifying Effects of Various Chemicals on Preneoplastic and Neoplastic Lesion Development in a Wide‐spectrum Organ Carcinogenesis Model Using F344 Rats (1991) (56)
- No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen. (2004) (56)
- Urinary sulfur-containing metabolite produced by intestinal bacteria following oral administration of dimethylarsinic acid to rats. (2003) (56)
- Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. (1987) (55)
- Different modifying response of butylated hydroxyanisole, butylated hydroxytoluene, and other antioxidants in N,N-dibutylnitrosamine esophagus and forestomach carcinogenesis of rats. (1987) (55)
- Sodium citrate: a promoter of bladder carcinogenesis. (1986) (55)
- Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats--association with oxidative DNA damage and enhanced cell proliferation. (2003) (55)
- Effects of sodium nitrite and catechol, 3-methoxycatechol, or butylated hydroxyanisole in combination in a rat multiorgan carcinogenesis model. (1993) (54)
- Possible carcinogenic potential of dimethylarsinic acid as assessed in rat in vivo models: a review. (1997) (53)
- Promotion of Skin Carcinogenesis by Dimethylarsinic Acid in Keratin (K6)/ODC Transgenic Mice (2000) (53)
- Inhibition of intestinal tumor development in rat multi-organ carcinogenesis and aberrant crypt foci in rat colon carcinogenesis by 22-oxa-calcitriol, a synthetic analogue of 1 alpha, 25-dihydroxyvitamin D3. (1995) (52)
- Chemopreventive Effects of Bovine Lactoferrin on N‐Butyl‐N‐(4‐ hydroxybutyl)nitrosamine‐induced Rat Bladder Carcinogenesis (2000) (52)
- Lack of carcinogenicity of butylated hydroxytoluene on long-term administration to B6C3F1 mice. (1982) (52)
- Elevation of 8-hydroxydeoxyguanosine and cell proliferation via generation of oxidative stress by organic arsenicals contributes to their carcinogenicity in the rat liver and bladder. (2007) (52)
- The role of urinary pH and sodium ion concentration in the promotion stage of two-stage carcinogenesis of the rat urinary bladder. (1988) (50)
- Detailed low‐dose study of 1,1‐b™IS(p‐chlorophenyl)‐2,2,2‐ trichloroethane carcinogenesis suggests the possibility of a hormetic effect (2002) (50)
- Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin. (2000) (50)
- Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. (1998) (50)
- Rat prostate as one of the target organs for 3,2'-dimethyl-4-aminobiphenyl-induced carcinogenesis: effects of dietary ethinyl estradiol and methyltestosterone. (1985) (50)
- Two-year inhalation study of carcinogenicity and chronic toxicity of 1,4-dioxane in male rats (2009) (49)
- Effect of phenobarbital, polychlorinated biphenyl and sodium saccharin on hepatic and renal carcinogenesis in unilaterally nephrectomized rats given N-ethyl-N-hydroxyethylnitrosamine orally. (1981) (49)
- Activated Akt expression has significant correlation with EGFR and TGF-alpha expressions in stage I NSCLC. (2004) (49)
- Mutagenic activation of urinary bladder carcinogens by CYP4B1 and the presence of CYP4B1 in bladder mucosa. (1997) (49)
- WIDE‐SPECTRUM INITIATION MODELS: POSSIBLE APPLICATIONS TO MEDIUM‐TERM MULTIPLE ORGAN BIOASSAYS FOR CARCINOGENESIS MODIFIERS (1988) (49)
- Induction of papilloma in the forestomach of hamsters by butylated hydroxyanisole. (1983) (49)
- Different carcinogenic responses in a variety of organs, including the prostate, of five different rat strains given 3,2'-dimethyl-4-aminobiphenyl. (1990) (48)
- Modification by catechol and resorcinol of upper digestive tract carcinogenesis in rats treated with methyl-N-amylnitrosamine. (1989) (48)
- Effects of subsequent antioxidant treatment on 7,12-dimethylbenz[a]anthracene-initiated carcinogenesis of the mammary gland, ear duct and forestomach in Sprague-Dawley rats. (1988) (48)
- Increased oxidative stress with gene alteration in urinary bladder urothelium after the Chernobyl accident (2000) (48)
- Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound. (1998) (48)
- Microbial metabolite of dimethylarsinic acid is highly toxic and genotoxic. (2004) (48)
- A new approach to chemoembolization for unresectable hepatocellular carcinoma using aclarubicin microspheres in combination with cisplatin suspended in iodized oil (1991) (47)
- N‐Methyl‐N‐nitrosourea Concentration‐dependent, Rather than Total Intake‐dependent, Induction of Adenocarcinomas in the Glandular Stomach of BALB/c Mice (1998) (46)
- Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis. (2011) (46)
- Existence of a threshold for induction of aberrant crypt foci in the rat colon with low doses of 2-amino-1-methyl-6-phenolimidazo[4,5-b]pyridine. (2004) (46)
- Carcinogenicity of multi-walled carbon nanotubes: challenging issue on hazard assessment (2017) (46)
- Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. (1995) (45)
- LESIONS OF THE URINARY BLADDER EPITHELIUM IN 125 AUTOPSY CASES (1981) (45)
- Carcinogenicity of phenacetin: Long‐term feeding study in B6C3F1 mice (1982) (45)
- Immunohistochemically demonstrated altered expression of cytochrome P-450 molecular forms and epoxide hydrolase in N-ethyl-N-hydroxyethylnitrosamine-induced rat kidney and liver lesions. (1987) (45)
- Changes in the urine and scanning electron microscopically observed appearance of the rat bladder following treatment with tumor promoters. (1986) (44)
- Responses of rat urine and urothelium to bladder tumor promoters: possible roles of prostaglandin E2 and ascorbic acid synthesis in bladder carcinogenesis. (1989) (43)
- L-ascorbic acid amplification of second-stage bladder carcinogenesis promotion by NaHCO3. (1988) (43)
- Participation of urinary Na+, K+, pH, and L-ascorbic acid in the proliferative response of the bladder epithelium after the oral administration of various salts and/or ascorbic acid to rats. (1989) (42)
- Influences of strain and diet on the promoting effects of sodium L-ascorbate in two-stage urinary bladder carcinogenesis in rats. (1987) (42)
- Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. (1978) (42)
- Carcinogenicity of catechol in F344 rats and B6C3F1 mice. (1993) (42)
- Neovascularization in benign and malignant urinary bladder epithelial proliferative lesions of the rat observed in situ by scanning electron microscopy and autoradiography. (1978) (42)
- Rational design of antitumor prostaglandins with high biological stability. (1998) (42)
- Organ-specific promoting effects of phenobarbital sodium and sodium saccharin in the induction of liver and urinary bladder tumors in male F344 rats. (1982) (41)
- Urinary bladder lesions induced by persistent chronic low‐dose ionizing radiation (2003) (41)
- Carcinogenicity of dimethylarsinic acid in Ogg1‐deficient mice (2007) (40)
- Impact of structural and metabolic variations on the toxicity and carcinogenicity of hydroxy- and alkoxy-substituted allyl- and propenylbenzenes. (2014) (40)
- Prostaglandin J2 and Related Compounds (1994) (40)
- Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident. (1999) (40)
- Two-week Toxicity of Multi-walled Carbon Nanotubes by Whole-body Inhalation Exposure in Rats (2013) (40)
- Etiology-specific gene expression profiles in rat mammary carcinomas. (2002) (40)
- Lack of carcinogenicity of enzymatically modified isoquercitrin in F344/DuCrj rats. (2004) (40)
- Two‐ and 13‐week Inhalation Toxicities of Indium‐tin Oxide and Indium Oxide in Rats (2011) (39)
- Correlation between Medium‐term Multi‐organ Carcinogenesis Bioassay Data and Long‐term Observation Results in Rats (1993) (39)
- The Urinary Excretion of Arsenic Metabolites After a Single Oral Administration of Dimethylarsinic Acid to Rats (1997) (39)
- Variation in tumor yield in the prostate and other target organs of the rat in response to varied dosage and duration of administration of 3,2'-dimethyl-4-aminobiphenyl. (1988) (39)
- Effect of quercetin on two-stage carcinogenesis of the rat urinary bladder. (1983) (38)
- A Medium-Term, Rapid Rat Bioassay Model for the Detection of Carcinogenic Potential of Chemicals (2010) (38)
- Promotion by dihydroxybenzene derivatives of N-methyl-N'-nitro-N-nitrosoguanidine-induced F344 rat forestomach and glandular stomach carcinogenesis. (1989) (38)
- Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model (1993) (38)
- Modification by antioxidants and p,p'-diaminodiphenylmethane of 7,12-dimethylbenz[a]anthracene-induced carcinogenesis of the mammary gland and ear duct in CD rats. (1986) (38)
- Effects of NaCl, Tween 60 and a low dose of N-ethyl-N'-nitro-N-nitrosoguanidine on gastric carcinogenesis of rat given a single dose of N-methyl-N'-nitro-N-nitrosoguanidine. (1982) (38)
- Intrahepatic bile duct proliferation induced by 4,4'-diaminodiphenylmethane in rats. (1979) (38)
- Alpha-benzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes. (2006) (37)
- Synchronous multiple primary gastrointestinal cancer exhibits frequent microsatellite instability. (2000) (37)
- A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response. (2006) (37)
- Development of a new multi-walled carbon nanotube (MWCNT) aerosol generation and exposure system and confirmation of suitability for conducting a single-exposure inhalation study of MWCNT in rats (2014) (36)
- Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. (2003) (36)
- Preparation of and drug release from W/O/W type double emulsions containing anticancer agents. (1983) (36)
- Control of drug release with a combination of prodrug and polymer matrix: antitumor activity and release profiles of 2',3'-diacyl-5-fluoro-2'-deoxyuridine from poly(3-hydroxybutyrate) microspheres. (1992) (35)
- Isolation of Differentiated Squamous and Undifferentiated Spindle Carcinoma Cell Lines with Differing Metastatic Potential from a 4‐Nitroquinoline N‐Oxide‐induced Tongue Carcinoma in a F344 Rat (2000) (35)
- Modifying Effects of Antioxidants on Chemical Carcinogenesis (1986) (35)
- S‐Methylcysteine and Cysteine Are Inhibitors of Induction of Glutathione S‐Transferase Placental Form‐positive Foci during Initiation and Promotion Phases of Rat Hepatocarcinogenesis (1997) (35)
- Lack of mutagenic and toxic effects of low dose potassium bromate on kidneys in the Big Blue rat. (2008) (34)
- Cytokeratin 8/18 overexpression and complex formation as an indicator of GST-P positive foci transformation into hepatocellular carcinomas (2009) (34)
- Catechol strongly enhances rat stomach carcinogenesis: a possible new environmental stomach carcinogen. (1987) (34)
- Oxidative Stress in the Carcinogenicity of Chemical Carcinogens (2013) (34)
- Inhibition of chemically induced liver carcinogenesis in Wistar rats by garlic (Allium sativum) (2000) (34)
- Cellular Differentiation and Histogenesis of Rat Glandular Stomach Cancers (1990) (33)
- Urinary bladder carcinogenesis induced by chronic exposure to persistent low-dose ionizing radiation after Chernobyl accident. (2009) (33)
- Enhancement of lung carcinogenesis by nonylphenol and genistein in a F344 rat multiorgan carcinogenesis model. (2003) (33)
- Modification by α-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine (1987) (33)
- Overexpression of Cyclin D1 in Rat Esophageal Carcinogenesis Model (1997) (32)
- Pulmonary Toxicity in Mice by 2‐ and 13‐week Inhalation Exposures to Indium‐tin Oxide and Indium Oxide Aerosols (2011) (32)
- Metabolism of dimethylarsinic acid in rats: production of unidentified metabolites in vivo (2001) (32)
- The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin‐induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver (2010) (31)
- Thirteen-week oral toxicity of 1,4-dioxane in rats and mice. (2008) (31)
- Skin Penetration Enhancing Action of cis-Unsaturated Fatty Acids with ω-9, and ω-12-Chain Lengths (1998) (31)
- ESTABLISHMENT OF MULTI-ORGAN CARCINOGENESIS BIOASSAY USING RATS TREATED WITH A COMBINATION OF FIVE DIFFERENT CARCINOGENS (1992) (30)
- Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine (2006) (30)
- Suppression of chemical carcinogenesis by water-soluble organosulfur compounds. (2001) (30)
- Effect of ethanol treatment on metabolic activation and detoxification of esophagus carcinogenic N-nitrosamines in rat liver. (2002) (30)
- DNA damage repair in bladder urothelium after the Chernobyl accident in Ukraine. (2002) (30)
- Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo. (1999) (30)
- Different genetic alterations in rat forestomach tumors induced by genotoxic and non-genotoxic carcinogens. (2002) (29)
- Aged garlic extract inhibits development of putative preneoplastic lesions in rat hepatocarcinogenesis. (2006) (29)
- Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats. (1987) (29)
- Evaluation of the toxicity of mastic gum with 13 weeks dietary administration to F344 rats. (2007) (29)
- Induction of CYP isoenzymes in various organs of rats by 3-methylcholanthrene or beta-naphthoflavone. (1995) (29)
- Co-carcinogenic effects of NaHCO3 on o-phenylphenol-induced rat bladder carcinogenesis. (1989) (29)
- Cytotoxicity of cis‐[((1R,2R)‐1,2‐Cyclohexanediamine‐N,N')bis(myristato)]‐platinum (II) Suspended in Lipiodol in a Newly Established Cisplatinresistant Rat Hepatoma Cell Line (2000) (29)
- Preparation of and drug release from W/O/W type double emulsions containing anticancer agents using an oily lymphographic agent as an oil phase. (1987) (29)
- Clonal analysis of urothelial carcinomas in C3H/HeN<-->BALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. (1998) (29)
- Carcinogenicity and chronic toxicity of hydrazine monohydrate in rats and mice by two-year drinking water treatment. (2016) (28)
- Translocation of intratracheally instilled multiwall carbon nanotubes to lung-associated lymph nodes in rats. (2011) (28)
- Lack of induction of epithelial cell proliferation by sodium saccharin and sodium L-ascorbate in the urinary bladder of NCI-black-Reiter (NBR) male rats. (1994) (28)
- Genetic instability and p53 mutations in metastatic foci of mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. (1997) (28)
- Presence of a no-observed effect level for enhancing effects of development of the α-isomer of benzene hexachloride (α-BHC) on diethylnitrosamine-initiated hepatic foci in rats (2001) (28)
- Medium-term bioassay for carcinogens using multiorgan models. (1991) (28)
- p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine. (1996) (28)
- Involvement of ubiquitination and sumoylation in bladder lesions induced by persistent long-term low dose ionizing radiation in humans. (2006) (28)
- Role of Na+, K+-ATPase α1 subunit in the intracellular accumulation of cisplatin (2005) (28)
- N-acetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage. (2006) (28)
- Effects of insulin on CYP3A activity and nicardipine disposition in streptozotocin-induced diabetic rats. (2010) (28)
- Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. (1986) (28)
- Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats. (1985) (28)
- Inhibition by ginseng of colon carcinogenesis in rats. (2001) (28)
- Antitumor effects of a novel lipophilic platinum complex (SM-11355) against a slowly-growing rat hepatic tumor after intra-hepatic arterial administration. (2000) (28)
- Mode of action of ethyl tertiary-butyl ether hepatotumorigenicity in the rat: evidence for a role of oxidative stress via activation of CAR, PXR and PPAR signaling pathways. (2013) (28)
- Intraarterial infusion of 5‐fluoro‐2‐deoxyuridine‐C8 dissolved in a lymphographic agent in malignant liver tumors. A preliminary report (1989) (28)
- Selective anticancer effects of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine, a lipophilic prodrug of 5-fluoro-2'-deoxyuridine, dissolved in an oily lymphographic agent on hepatic cancer of rabbits bearing VX-2 tumor. (1987) (27)
- The disposition of pravastatin in a rat model of streptozotocin-induced diabetes and organic anion transporting polypeptide 2 and multidrug resistance-associated protein 2 expression in the liver. (2010) (27)
- Chemopreventive effect of 24R,25-dihydroxyvitamin D(3) in N, N'-dimethylhydrazine-induced rat colon carcinogenesis. (2000) (27)
- Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms. (2005) (27)
- Antitumor activity, optimum administration method and pharmacokinetics of 13,14-dihydro-15-deoxy-δ7-prostaglandin A1 methyl ester (TEI-9826) integrated in lipid microspheres (Lipo TEI-9826) (2001) (27)
- Promotion by L-ascorbic acid of urinary bladder carcinogenesis in rats under conditions of increased urinary K ion concentration and pH. (1987) (27)
- Updated procedure for the safety evaluation of natural flavor complexes used as ingredients in food. (2018) (27)
- Dimethylarsinic acid induces 8-hydroxy-2'-deoxyguanosine formation in the kidney of NCI-Black-Reiter rats. (2001) (27)
- Thirteen‐week Inhalation Toxicity of Carbon Tetrachloride in Rats and Mice (2007) (27)
- Promotive effect of primary and secondary bile acids on the induction of gamma-glutamyl transpeptidase-positive liver cell foci as a possible endogenous factor for hepatocarcinogenesis in rats. (1984) (27)
- Effect of absorption rate on pharmacokinetics of ibuprofen in relation to chiral inversion in humans (2007) (26)
- Carcinogenicity of quinoline, styrene, and styrene-7,8-oxide. (2018) (26)
- Expression of the cyclin D1 gene in rat colorectal aberrant crypt foci and tumors induced by azoxymethane. (1999) (26)
- In vitro release of SM-11355, cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)] platinum(II) suspended in lipiodol. (2000) (26)
- Inhibitory effect of 4,4'-diaminodiphenylmethane on liver, kidney and bladder carcinogenesis in rats ingesting N-ethyl-N-hydroxyethylnitrosamine or N-butyl-N-(4-hydroxybutyl) nitros-amine. (1981) (26)
- Significant overexpression of metallothionein and cyclin D1 and apoptosis in the early process of rat urinary bladder carcinogenesis induced by treatment with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium L-ascorbate. (2000) (26)
- Enhancing effects of sodium phenobarbital and N,N-dibutylnitrosamine on tumor development in a rat wide-spectrum organ carcinogenesis model. (1990) (25)
- Strain Differences in N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine Bladder Carcinogenesis in Rats (1988) (25)
- Modification by sodium L-ascorbate, butylated hydroxytoluene, phenobarbital and pepleomycin of lesion development in a wide-spectrum initiation rat model. (1989) (25)
- Inhalation carcinogenicity and toxicity of 1,2-dichloropropane in rats (2010) (25)
- Inhibition by Ginseng of 1,2-Dimethylhydrazine Induction of Aberrant Crypt Foci in the Rat Colon (2000) (25)
- Effects of oleic acid/propylene glycol on rat abdominal stratum corneum: lipid extraction and appearance of propylene glycol in the dermis measured by Fourier transform infrared/attenuated total reflectance (FT-IR/ATR) spectroscopy. (1993) (25)
- The Modifying Effects of Indomethacin or Ascorbic Acid on Cell Proliferation Induced by Different Types of Bladder Tumor Promoters in Rat Urinary Bladder and Forestomach Mucosal Epithelium (1992) (25)
- Role of oxidative DNA damage caused by carbon tetrachloride-induced liver injury -- enhancement of MeIQ-induced glutathione S-transferase placental form-positive foci in rats. (2002) (25)
- Immunohistochemical demonstration of carcinogen-DNA adducts in target and non-target tissues of rats given a prostate carcinogen, 3,2'-dimethyl-4-aminobiphenyl. (1990) (25)
- alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers. (2004) (24)
- Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1. (1985) (24)
- Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. (2000) (24)
- Intestinal metaplasia and altered enzyme expression in propylnitrosamine-induced Syrian hamster cholangiocellular and gallbladder lesions (1986) (24)
- Dose-related induction of lung, thyroid and kidney tumors by N-bis(2-hydroxypropyl)nitrosamine given orally to F344 rats. (1984) (24)
- Enzymatic and chemical stability of 2',3'-dideoxy-2',3'-didehydropyrimidine nucleosides: potential anti-acquired immunodeficiency syndrome agents. (1989) (24)
- Effects of phenolic antioxidants in low dose combination on forestomach carcinogenesis in rats pretreated with N-methyl-N'-nitro-N-nitrosoguanidine. (1991) (24)
- Hormonally active doses of isoflavone aglycones promote mammary and endometrial carcinogenesis and alter the molecular tumor environment in Donryu rats. (2012) (23)
- Time‐ and Dose‐dependent Induction of Invasive Urinary Bladder Cancers by N‐Ethyl‐N‐(4‐hydroxybutyl)nitrosamine in B6C3F1 Mice (1991) (23)
- Modification of chemical carcinogenesis by antioxidants. (1983) (23)
- Promotion by Sodium L‐Ascorbate in Rat Two‐stage Urinary Bladder Carcinogenesis is Dependent on the Interval of Administration (1999) (23)
- Membrane potentials of urinary bladder epithelium in F344 rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium saccharin. (1983) (23)
- Methylation and Demethylation of Dimethylarsinic Acid in Rats Following Chronic Oral Exposure (1996) (23)
- Enhancing Effects of Organosulfur Compounds from Garlic and Onions on Hepatocarcinogenesis in Rats: Association with Increased Cell Proliferation and Elevated Ornithine Decarboxylase Activity (1994) (23)
- Enteric bacteria may play a role in mammalian arsenic metabolism (2001) (23)
- Regression of simple hyperplasia and papillomas and persistence of basal cell hyperplasia in the forestomach of F344 rats treated with butylated hydroxyanisole. (1987) (23)
- Anticancer activity of free gamma-linolenic acid on AH-109A rat hepatoma cells and the effect of serum albumin on anticancer activity of gamma-linolenic acid in vitro. (1990) (23)
- Organ-specific, carcinogen-induced increases in cell proliferation in p53-deficient mice. (2000) (23)
- Carcinogenicity of captafol in B6C3F1 mice. (1984) (22)
- Evidence of a Threshold-Effect for 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline Liver Carcinogenicity in F344/DuCrj Rats (2008) (22)
- Medium-term multi-organ carcinogenesis bioassay of ethyl tertiary-butyl ether in rats. (2011) (22)
- Structure‐Activity Relations in Promotion of Rat Urinary Bladder Carcinogenesis by Phenolic Antioxidants (1990) (22)
- In vivo positive mutagenicity of 1,4-dioxane and quantitative analysis of its mutagenicity and carcinogenicity in rats (2018) (22)
- Induction of forestomach hyperplasia by crude butylated hydroxyanisole, a mixture of 3-tert and 2-tert isomers, in Syrian golden hamsters is due to 3-tert-butylated hydroxyanisole. (1984) (22)
- Reversibility and apoptosis in rat urinary bladder papillomatosis induced by uracil. (1997) (22)
- Testicular toxicity of DEHP, but not DEHA, is elevated under conditions of thioacetamide-induced liver damage. (2006) (22)
- Absence of promotion potential for calcium L-ascorbate, L-ascorbic dipalmitate, L-ascorbic stearate and erythorbic acid on rat urinary bladder carcinogenesis. (1987) (21)
- Possible distinct molecular carcinogenic pathways for bladder cancer in Ukraine, before and after the Chernobyl disaster. (2004) (21)
- Cleistocalyx nervosum extract ameliorates chemical-induced oxidative stress in early stages of rat hepatocarcinogenesis. (2014) (21)
- Modifying factors in urinary bladder carcinogenesis (1983) (21)
- Spermidine/Spermine N‐Acetyltransferase, a New Biochemical Marker for Epithelial Proliferation in Rat Bladder (1992) (21)
- Organ‐specific Modification of Tumor Development by Low‐dose Combinations of Agents in a Rat Wide‐spectrum Carcinogenesis Model (1991) (21)
- Carcinogenicity of ortho-phenylenediamine dihydrochloride in rats and mice by two-year drinking water treatment (2012) (21)
- Treated natural history of superficial bladder cancer. (2001) (21)
- Induction of glutathione S-transferase placental form positive foci in liver and epithelial hyperplasia in urinary bladder, but no tumor development in male Fischer 344 rats treated with monomethylarsonic acid for 104 weeks. (2003) (21)
- Behavior of propylene glycol (PG) in dermis after treatment of rat intact skin surface with fatty acids, fatty amines or azone dissolved in PG. (1995) (21)
- Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines (2005) (21)
- Lack of large intestinal carcinogenicity of 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine at low doses in rats initiated with azoxymethane (2005) (21)
- Enhancement by estradiol 3-benzoate in thioacetamide-induced liver cirrhosis of rats. (2005) (21)
- FEMA GRAS assessment of natural flavor complexes: Citrus-derived flavoring ingredients. (2019) (21)
- Modifying effects of phytic acid and gamma-oryzanol on the promotion stage of rat carcinogenesis. (1999) (21)
- Non-genotoxic mode of action and possible threshold for hepatocarcinogenicity of Kojic acid in F344 rats. (2011) (21)
- Characteristics of multiwall carbon nanotubes for an intratracheal instillation study with rats. (2010) (21)
- Inhalation Carcinogenicity and Chronic Toxicity of Carbon Tetrachloride in Rats and Mice (2007) (20)
- CURRENT METHODS OF ASSESSING AND TREATING CARCINOMA IN SITU OF THE BLADDER WITH OR WITHOUT INVOLVEMENT OF THE PROSTATIC URETHRA (1995) (20)
- Subchronic toxicity and carcinogenicity studies of 1,2-dichloropropane inhalation to mice (2013) (20)
- A Rapid in vivo Bioassay for the Carcinogenicity of Pesticides (1991) (20)
- Hepatotumorigenicity of ethyl tertiary-butyl ether with 2-year inhalation exposure in F344 rats (2013) (20)
- Renal Pelvic Carcinoma Producing Granulocyte Colony-Stimulating Factor: Report of a Case (2001) (20)
- Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens. (2016) (20)
- Modifying effects of concomitant treatment with butylated hydroxyanisole or butylated hydroxytoluene on N,N-dibutylnitrosamine-induced liver, forestomach and urinary bladder carcinogenesis in F344 male rats. (1988) (19)
- Enhancement of propylene glycol distribution in the skin by high purity cis-unsaturated fatty acids with different alkyl chain lengths having different double bond position. (1999) (19)
- Anticancer effects of free polyunsaturated fatty acids in an oily lymphographic agent following intrahepatic arterial administration to a rabbit bearing VX-2 tumor. (1992) (19)
- Long-term toxicity and carcinogenicity study of sodium o-phenylphenate in B6C3F1 mice. (1984) (19)
- Low‐dose carcinogenicity of 2‐amino‐3‐methylimidazo[4,5‐f ]quinoline in rats: Evidence for the existence of no‐effect levels and a mechanism involving p21Cip / WAF1 (2011) (19)
- FEMA GRAS assessment of natural flavor complexes: Mint, buchu, dill and caraway derived flavoring ingredients. (2019) (19)
- Metabolites of arsenobetaine in rats : does decomposition of arsenobetaine occur in mammals? (2001) (19)
- Dose and sex dependent effects of 2-acetylaminofluorene, 3'-methyl-4-dimethylaminoazobenzene and DL-ethionine in induction of gamma-glutamyl transpeptidase-positive liver cell foci in rats. (1983) (19)
- The increases in relative mRNA expressions of inflammatory cytokines and chemokines in splenic macrophages from rats exposed to multi-walled carbon nanotubes by whole-body inhalation for 13 weeks (2014) (19)
- Carcinogenicity of Methylurea or Morpholine in Combination with Sodium Nitrite in a Rat Multi‐organ Carcinogenesis Bioassay (1997) (18)
- Lack of potential of low dose N-nitrosodimethylamine to induce preneoplastic lesions, glutathione S-transferase placental form-positive foci, in rat liver. (2005) (18)
- Strain Differences in Sensitivity to the Promoting Effect of Sodium L‐Ascorbate in a Two‐stage Rat Urinary Bladder Carcinogenesis Model (1997) (18)
- The safety evaluation of food flavouring substances: the role of metabolic studies. (2018) (18)
- Inhibition of liver glutathione S-transferase placental form-positive foci development in the rat hepatocarcinogenesis by Porphyra tenera (Asakusa-nori). (1999) (18)
- Selective induction of rat urinary bladder tumors by simultaneous administration of 3,2'-dimethyl-4-aminobiphenyl (DMAB) and butylated hydroxyanisole or butylated hydroxytoluene is associated with increased DMAB-DNA adduct formation. (1991) (18)
- Calculi, precipitates and microcrystalluria associated with irritation and cell proliferation as a mechanism of urinary bladder carcinogenesis in rats and mice. (1999) (17)
- Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats. (2006) (17)
- Continuous exposure to low-dose cisplatin and apoptosis. (2005) (17)
- Lack of Promoting Effects of α‐Linolenic, Linoleic or Palmitic Acid on Urinary Bladder Carcinogenesis in Rats (1995) (17)
- Sex Differences in o‐Phenylphenol and Sodium o‐Phenylphenate Rat Urinary Bladder Carcinogenesis: Urinary Metabolites and Electrolytes under Conditions of Aciduria and Alkalinuria (1991) (17)
- Effects of Sodium Nitrite and Catechol or 3‐Methoxycatechol in Combination on Rat Stomach Epithelium (1990) (17)
- Inhibitory effects of the dietary antioxidants butylated hydroxyanisole and butylated hydroxytoluene on bronchioloalveolar cell proliferation during the bleomycin-induced pulmonary fibrosing process in hamsters. (1996) (17)
- Lack of carcinogenicity of magnesium chloride in a long-term feeding study in B6C3F1 mice. (1989) (17)
- Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. (2003) (17)
- Promoting Effect of the Peroxisome Proliferator, Clofibrate, but Not Di(2‐ethylhexyl)phthalate, on Urinary Bladder Carcinogenesis in F344 Rats Initiated by N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine (1990) (17)
- GRASr2 evaluation of aliphatic acyclic and alicyclic terpenoid tertiary alcohols and structurally related substances used as flavoring ingredients. (2014) (17)
- Inhibition of Development of N, N′‐Dimethylhydrazine‐induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R,25‐Dihydroxyvitamin D3 (1997) (17)
- Summation and synergism in the promotion of urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine in F344 rats. (1984) (17)
- Carcinogenicities of quinoline derivatives in F344 rats. (1981) (17)
- Comparison of single or multiple intratracheal administration for pulmonary toxic responses of nickel oxide nanoparticles in rats (2016) (17)
- Urinary Bladder Lesions after the Chernobyl Accident: Immunohistochemical Assessment of p53, Proliferating Cell Nuclear Antigen, Cyclin D1 and p21WAF1/Cip1 (1999) (16)
- Inorganic Alkalizers and Acidifiers under Conditions of High Urinary Na+ or K+ on Cell Proliferation and Two‐stage Carcinogenesis in the Rat Bladder (1992) (16)
- Potassium Bromate Enhances N-Ethyl-N-Hydroxyethylnitrosamine–Induced Kidney Carcinogenesis Only at High Doses in Wistar Rats: Indication of the Existence of an Enhancement Threshold (2009) (16)
- High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice. (2007) (16)
- Determination of trivalent methylated arsenicals in rat urine by liquid chromatography-inductively coupled plasma mass spectrometry after solvent extraction. (2004) (16)
- Immunohistochemical Analysis of c‐erbB‐2 Oncogene Product and Epidermal Growth Factor Receptor Expression in Human Urinary Bladder Carcinomas (1990) (16)
- Chemopreventive Effects of Coumaperine from Pepper on the Initiation Stage of Chemical Hepatocarcinogenesis in the Rat (2000) (16)
- Hormesis in Carcinogenicity of Non-genotoxic Carcinogens (2006) (16)
- The safety evaluation of food flavoring substances: the role of genotoxicity studies (2020) (16)
- Pathological analysis of the carcinogenicity of sodium o-phenylphenate and o-phenylphenol. (1985) (16)
- Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis. (1984) (16)
- An LC-MS/MS Method for Absolute Quantification of Nivolumab in Human Plasma: Application to Clinical Therapeutic Drug Monitoring (2018) (16)
- In vitro chromosomal aberrations induced by various shapes of multi-walled carbon nanotubes (MWCNTs) (2016) (16)
- Disappearance of upward proliferation and persistence of downward basal cell proliferation in rat forestomach papillomas induced by butylated hydroxyanisole. (1986) (16)
- Persistence of Liver Cirrhosis in Association with Proliferation of Nonparenchymal Cells and Altered Location of α-Smooth Muscle Actin-Positive Cells (2005) (16)
- Role of Na+, K+-ATPase alpha1 subunit in the intracellular accumulation of cisplatin. (2006) (16)
- Dose-response study of urinary bladder carcinogenesis in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine (2004) (15)
- Food Restriction Inhibits the Growth of Intestinal Polyps in Multiple Intestinal Neoplasia Mouse (2002) (15)
- Lack of tumorigenic response in the prostate gland of castrated F344 rats by 3,2'-dimethyl-4-aminobiphenyl given with methyltestosterone. (1987) (15)
- Novel method using hybrid markers: development of an approach for pulmonary measurement of multi-walled carbon nanotubes (2013) (15)
- Different dose-response relationships in the induction of different types of colonic tumors in Wistar rats by 1,2-dimethylhydrazine. (1983) (15)
- Tumours of the Urinary Bladder (1936) (15)
- Carcinogenicity of 8-nitroquinoline in Sprague-Dawley rats. (1978) (15)
- Aging and urinary bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine. (1987) (15)
- Human and environmental health challenges for the next decade (2010–2020) (2010) (15)
- FEMA GRAS assessment of natural flavor complexes: Clove, Cinnamon leaf and West Indian bay leaf-derived flavoring ingredients. (2020) (15)
- Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine. (1999) (15)
- Synchronous multiple primary gastrointestinal cancer exhibits frequent microsatellite instability (2000) (15)
- Modification of tumor development in the urinary bladder. (1991) (15)
- Safety evaluation of substituted thiophenes used as flavoring ingredients. (2017) (15)
- Valerian Inhibits Rat Hepatocarcinogenesis by Activating GABA(A) Receptor-Mediated Signaling (2014) (14)
- Thirteen-Week Inhalation Toxicity of 1,4-Dioxane in Rats (2008) (14)
- Qualitative and Quantitative Assessments on Low-Dose Carcinogenicity of Genotoxic Hepatocarcinogens: Dose–Response for Key Events in Rat Hepatocarcinogenesis (2016) (14)
- Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats. (1987) (14)
- Low-dose carcinogenicity of a heterocyclic amine, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: relevance to risk assessment. (1999) (14)
- Regulatory Forum Opinion Piece* (2014) (14)
- L-ascorbic acid amplification of bladder carcinogenesis promotion by K2CO3. (1991) (14)
- Effects of sodium L-ascorbate and related compounds on rat stomach carcinogenesis initiated by N-methyl-N'-nitro-N-nitrosoguanidine. (1985) (14)
- Relation between intracellular accumulation and cytotoxic activity of cis-[((1R, 2R)-1, 2-cyclohexanediamine-N, N')bis(myristato)]platinum(II) suspended in Lipiodol. (2003) (14)
- Development and validation of a method for gefitinib quantification in dried blood spots using liquid chromatography-tandem mass spectrometry: Application to finger-prick clinical blood samples of patients with non-small cell lung cancer. (2018) (13)
- HISTOCHEMICAL DEMONSTRATION OF COLONIC TYPE MUCIN IN GLANDULAR METAPLASIA and ADENOCARCINOMA OF THE HUMAN URINARY BLADDER (1987) (13)
- Effects of Age on Multiple Organ Carcinogenesis Induced by 3,2′‐Dimethyl‐4‐aminobiphenyl in Rats, with Particular Reference to the Prostate (1989) (13)
- [Glutamate transporter mediated increase of antitumor activity by theanine, an amino acid in green tea]. (2002) (13)
- Lack of a modifying effect by the diuretic drug furosemide on the development of neoplastic lesions in rat two-stage urinary bladder carcinogenesis. (1989) (13)
- Synthesis of somatostatin analogues containing C-terminal adamantane and their antiproliferative properties. (2008) (13)
- Roles of bladder distension, urinary pH and urinary sodium ion concentration in cell proliferation of urinary bladder epithelium in rats ingesting sodium salts. (1994) (13)
- LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. (1999) (13)
- Synergism of Environmental Carcinogens and Promoters on Bladder Cancer Development Initiated by N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine in F344 Rats (1992) (13)
- CURRENT METHODS OF ASSESSING AND TREATING CARCINOMA IN SITU OF THE BLADDER WITH OR WITHOUT INVOLVEMENT OF THE PROSTATIC URETHRA (1995) (13)
- Influences of aging and sex on renal pelvic carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice. (1994) (13)
- High susceptibility of p53 knockout mice to esophageal and urinary bladder carcinogenesis induced by N, N-dibutylnitrosamine. (2003) (13)
- Application of liquid chromatography-tandem mass spectrometry for the determination of opioidmimetics in the brain dialysates from rats treated with opioidmimetics intraperitoneally. (2004) (13)
- Lack of promoting effect due to oral administration of dimethylarsinic acid on rat lung carcinogenesis initiated with N-bis(2-hydroxypropyl)nitrosamine. (2002) (13)
- Dose-Dependent Amplification by L-Ascorbic Acid of NaHCO3 Promotion of Rat Urinary Bladder Carcinogenesis (1997) (13)
- Induction of the Renal Peiyic and Ureteral Carcinomas by N-Butyl-N-(4-Hydroxybutyl)nitrosamine in SD/cShi Rats with Spontaneous Hydronephrosis (1994) (12)
- Dose‐dependence of promotion of 2‐amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline‐induced rat hepatocarcinogenesis by ethanol: Evidence for a threshold (2005) (12)
- Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53. (1999) (12)
- FEMA GRAS assessment of natural flavor complexes: Cinnamomum and Myroxylon-derived flavoring ingredients. (2019) (12)
- Relationship between Paronychia and Drug Concentrations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (2018) (12)
- Initiation-promotion model for assessment of carcinogenicity: medium-term liver bioassay in rats for rapid detection of carcinogenic agents. (1996) (12)
- FEMA GRAS assessment of natural flavor complexes: Lavender, Guaiac Coriander-derived and related flavoring ingredients. (2020) (12)
- Altered expression of MRP2, MRP3 and UGT2B1 in the liver affects the disposition of morphine and its glucuronide conjugate in a rat model of cholestasis (2009) (12)
- Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide‐induced liver damage in rats (2006) (12)
- Dose-dependent induction of aberrant crypt foci in the colons but no neoplastic lesions in the livers of heterozygous p53-deficient mice treated with low dose 2-amino-3-methylimidazo [4,5-f]quinoline. (1999) (12)
- In vitro Antitumor Activity, Intracellular Accumulation, and DNA Adduct Formation of cis‐[((1R, 2R)‐1,2‐Cyclohexanediamine‐N, N')bis(myristato)] Platinum (II) Suspended in Lipiodol (2000) (12)
- Population Pharmacokinetic-Toxicodynamic Modeling and Simulation of Cisplatin-Induced Acute Renal Injury in Rats: Effect of Dosing Rate on Nephrotoxicity. (2016) (12)
- CYTOPATHOLOGICAL EFFECT OF PARTIAL CYSTECTOMY OF RATS (1981) (12)
- Effects of pinocembrin on the initiation and promotion stages of rat hepatocarcinogenesis. (2012) (12)
- Thresholds for Genotoxic Carcinogens: Evidence from Mechanism‐Based Carcinogenicity Studies (2010) (12)
- Enhanced hepatocarcinogenicity by combined inhalation and oral exposures to N,N-dimethylformamide in male rats. (2009) (12)
- Enhancing risk of ethanol on MeIQx-induced rat hepatocarcinogenesis is accompanied with increased levels of cellular proliferation and oxidative stress. (2003) (12)
- Immunohistochemical expression of keratin proteins in urinary bladder carcinoma. (1989) (11)
- Toxicity vs. beneficial effects of phytoestrogens (2003) (11)
- Application of a lipophilic platinum derivative contained in an oily lymphographic agent to intra-hepatic arterial chemotherapy (1992) (11)
- Host genes affecting survival period of chemically induced bladder cancer in mice (1998) (11)
- Long-term toxicity and carcinogenicity test of ammonia-process caramel colouring given to B6C3F1 mice in the drinking-water. (1983) (11)
- Mechanism for 6-methylcoumarin photoallergenicity. (1985) (11)
- No carcinogenicity of ethyl tertiary-butyl ether by 2-year oral administration in rats. (2012) (11)
- Altered expression of nuclear receptors affects the expression of metabolic enzymes and transporters in a rat model of cholestasis. (2009) (11)
- Chemopreventive effects of a serratane-type triterpenoid, 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1), against rat lung carcinogenesis. (2008) (11)
- Bladder epithelial hyperplasia in F344 rats after intravesical instillation of the antitumor chemotherapeutic agents Adriamycin and mitomycin C. (1990) (10)
- Effects of sodium L-ascorbate, uracil, butylated hydroxyanisole and extracellular pH on junctional intercellular communication of BALB/c 3T3 cells. (1988) (10)
- Current and emerging challenges in toxicopathology: carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens. (2005) (10)
- Inhibitory Effects of S‐Methylcysteine and Cysteine on the Promoting Potential of Sodium Phenobarbital on Rat Liver Carcinogenesis (2000) (10)
- Enhancing effects of an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in a multi‐organ carcinogenesis bioassay (1994) (10)
- [Experimental study of hepatic arterial embolization therapy by various formulations of the anticancer agent lipiodol]. (1985) (10)
- Presence of a no-observed effect level for enhancing effects of development of the alpha-isomer of benzene hexachloride (alpha-BHC) on diethylnitrosamine-initiated hepatic foci in rats. (2001) (10)
- Assessment of L-ascorbic acid requirement for prolonged survival in ODS rats and their susceptibility to urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine. (1988) (10)
- Transdermal drug delivery by electroporation applied on the stratum corneum of rat using stamp-type electrode and frog-type electrode in vitro. (2001) (10)
- Possible tumor development from double positive foci for TGF‐alpha and GST‐P observed in early stages on rat hepatocarcinogenesis (2006) (10)
- Comprehensive analysis of DNA adducts (DNA adductome analysis) in the liver of rats treated with 1,4-dioxane (2020) (10)
- Existence of No Hepatocarcinogenic Effect Levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without Coadministration with Ethanol (2006) (10)
- Enhanced proliferative response of hepatocytes to combined inhalation and oral exposures to N,N-dimethylformamide in male rats. (2008) (10)
- Dose-dependent inhibition of glutathione S-transferase placental form-positive hepatocellular foci induction in the rat by methyl propyl disulfide and propylene sulfide from garlic and onions. (1994) (10)
- Influence of Aging on Multi‐organ Carcinogenesis in Rats Induced by N‐Methyl‐N‐nitrosourea (1993) (10)
- Lack of change in the levels of liver and kidney cytochrome P-450 isozymes in p53+/- knockout mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. (2001) (9)
- Modification of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in rats by phytic acid and its salts. (1994) (9)
- Quantitative evaluation of the pulmonary microdistribution of TiO2 nanoparticles using X‐ray fluorescence microscopy after intratracheal administration with a microsprayer in rats (2015) (9)
- Combined effects of L-ascorbic acid, citric acid or their sodium salts on tumor induction by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-ethyl-N-(4-hydroxybutyl)nitrosamine in the rat urinary bladder. (1988) (9)
- Proliferative response of renal pelvic epithelium in rats to oral administration of ortho-phenylphenol, sodium ortho-phenylphenate and diphenyl. (1989) (9)
- Change of membrane potential in rat urinary bladder epithelium treated with sodium L-ascorbate. (1992) (9)
- Concentration dependent promoting effects of sodium L-ascorbate with the same total dose in a rat two-stage urinary bladder carcinogenesis. (1999) (9)
- Improved method for measurement of multi-walled carbon nanotubes in rat lung (2016) (9)
- GRAS 28 flavoring substances (2018) (9)
- Establishment and characterization of a human colonic mucinous carcinoma cell line with predominant goblet‐cell differentiation from liver metastasis (2005) (9)
- p53 Status in Multiple Human Urothelial Cancers: Assessment for Clonality by the Yeast p53 Functional Assay in Combination with p53 Immunohistochemistry (2000) (9)
- Comparison of enzyme phenotypes in human bladder tumours and experimentally induced hyperplastic and neoplastic lesions of the rat urinary bladder (1988) (9)
- Significance of Cyclin D1 Overexpression in Transitional Cell Carcinomas of the Urinary Bladder and its Correlation with Histopathological Features (1997) (9)
- Progression of Hepatic Adenoma to Carcinoma in Ogg1 Mutant Mice Induced by Phenobarbital (2017) (9)
- Upregulation of fibroblast growth factor receptor 3 and epidermal growth factor receptors, in association with Raf‐1, in urothelial dysplasia and carcinoma in situ after the Chernobyl accident (2006) (9)
- FEMA expert panel review of p-mentha-1,8-dien-7-al genotoxicity testing results. (2016) (9)
- Cell proliferation in lung fibrosis-associated hyperplastic lesions (1995) (9)
- p53 and H‐ras Mutations and Microsatellite Instability in Renal Pelvic Carcinomas of NON/Shi Mice Treated with N‐Butyl‐N‐(4‐hydroxybutyl)‐nitrosamine: Different Genetic Alteration from Urinary Bladder Carcinoma (2001) (8)
- Observational retrospective single‐centre study in Japan to assess the clinical significance of serum daptomycin levels in creatinine phosphokinase elevation (2019) (8)
- Inhibition of rat urinary bladder carcinogenesis by the antiangiogenic drug TNP-470. (2006) (8)
- Chemopreventive effects of 13alpha,14alpha-epoxy-3beta-methoxyserratan-21beta-ol (PJJ-34), a serratane-type triterpenoid, in a rat multi-organ carcinogenesis bioassay. (2010) (8)
- Development of an LC-MS/MS-based method for quantitation of osimertinib in human plasma and cerebrospinal fluid. (2019) (8)
- An improved system for exposure of cultured mammalian cells to gaseous compounds in the chromosomal aberration assay. (2008) (8)
- Subchronic toxicity study of methyl hesperidin in mice. (1993) (8)
- FEMA GRAS assessment of natural flavor complexes: Origanum oil, thyme oil and related phenol derivative-containing flavoring ingredients. (2021) (8)
- Promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in rats. (1985) (8)
- Lack of promotion of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in mice by rat cancer promoters. (1993) (8)
- 34 – Lower Urinary Tract (2002) (8)
- Cell cycle arrest triggered by conjugated eicosapentaenoic acid occurs through several mechanisms including G1 checkpoint activation by induced RPA and ATR expression. (2009) (8)
- Modification by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) of 3,2'-dimethyl-4-aminobiphenyl (DMAB)-induced rat pancreatic and intestinal tumorigenesis. (1998) (8)
- Lazarus Response to Tepotinib for Leptomeningeal Metastases in a Patient With MET Exon 14 Skipping Mutation–Positive Lung Adenocarcinoma: Case Report (2021) (8)
- Inhibitory effects of procainamide and probenecid on renal excretion of sultopride enantiomers in rats. (1993) (8)
- Chemopreventive effects of S-methylcysteine on rat hepatocarcinogenesis induced by concurrent administration of sodium nitrite and morpholine. (2000) (8)
- [Background data of spontaneous tumors in F344/DuCrlCrlj rats]. (2015) (8)
- JTE‐522, a selective cyclooxygenase‐2 inhibitor, inhibits induction but not growth and invasion of 1,2‐dimethylhydrazine‐induced tubular adenocarcinomas of colon in rats (2005) (7)
- Comparative Study of Urinary Bladder Carcinomas in Japanese and Egyptians (1989) (7)
- Carcinogenesis, Urinary Tract, Rat (1986) (7)
- Effects of bisphosphonates on human esophageal squamous cell carcinoma cell survival. (2016) (7)
- Effect of hepatotoxic or nephrotoxic agents on the induction of colon cancers in rats by 1,2-dimethylhydrazine. (1977) (7)
- Design and performance of a system for blood collection of rats under whole-body inhalation exposure. (2009) (7)
- White, but not Red, Ginseng Inhibits Progression of Intestinal Carcinogenesis in Rats. (2002) (7)
- Induction of smooth muscle cells in the fibrous capsule of human hepatocellular carcinoma but not in the septa of hepatic cirrhosis (1999) (7)
- Effects of insulin on CYP3A activity and nicardipine disposition in streptozotocin‐induced diabetic rats (2010) (7)
- Lack of enhancing effects of fenvalerate and esfenvalerate on induction of preneoplastic glutathione S-transferase placental form positive liver cell foci in rats. (1990) (7)
- Comparative promoting activities of phosphate salts on rat two-stage bladder carcinogenesis under conditions of equivalent urinary Na+ or K+ levels. (1991) (7)
- Inter‐laboratory comparison of pulmonary lesions induced by intratracheal instillation of NiO nanoparticle in rats: Histopathological examination results (2020) (7)
- Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mice. (2006) (7)
- Long-term feeding study of N,N'-diphenyl-p-phenylenediamine in F344 rats. (1989) (7)
- Chloroform distribution and accumulation by combined inhalation plus oral exposure routes in rats (2010) (7)
- Squamous Cell Carcinoma Forestomach, Rat (1997) (7)
- Epithelial cell proliferation in the digestive tract induced by space restriction and water-immersion stress. (1998) (7)
- The roles of L-ascorbic acid, urinary pH, and Na or K ion concentration in rat bladder epithelial cell proliferation with special reference to tumor promotion. (1991) (7)
- Region-specific patterns of mucin reaction demonstrated by paradoxical concanavalin A-staining in normal colonic epithelium and in colorectal cancers induced in rats by 1,2-dimethylhydrazine. (1982) (7)
- Skin penetration enhancing action of cis-unsaturated fatty acids with omega-9, and omega-12-chain lengths. (1998) (7)
- Thirteen-week inhalation toxicity of 1,4-dioxane in rats. (2008) (7)
- Quantitative Approaches to Assess Key Carcinogenic Events of Genotoxic Carcinogens (2018) (7)
- Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphisms (2018) (7)
- Combined chronic toxicity and carcinogenicity studies of morpholine oleic acid salt in B6C3F1 mice. (1987) (7)
- Selective accumulation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) and sustained release of its active metabolites in VX-2 rabbit hepatoma following intraarterial administration of FdUrd-C8 solution in Lipiodol. (1988) (7)
- Induction of tumors in the colon and liver of the immunodeficient (SCID) mouse by 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ)-modulation by long-chain fatty acids. (2002) (7)
- Possible rare involvement of O6-methylguanine formation as a significant mutational factor in mouse urinary bladder carcinogenesis models. (1998) (7)
- Modification of carcinogenesis by antioxidants and other compounds. (1984) (7)
- Experimental study of hepatic artery embolization: evaluation of various embolic materials. (1987) (7)
- Aberrant expression of E‐cadherin and β‐catenin in association with transforming growth factor‐β1 in urinary bladder lesions in humans after the Chernobyl accident (2006) (7)
- Existence of a Threshold for the Genotoxic Carcinogens: Evidence from Mechanism-based Carcinogenicity Studies (2009) (6)
- A case report of inflammatory pseudotumor of the urinary bladder. (1995) (6)
- GRAS Flavoring Substances 25. The 25th publication by the Expert Panel of the Flavor and Extract Manufacturers Association provides an update on reent progress in the consideration of flavoring ingredients generally recognized as safe under the Food Additives Amendment (2011) (6)
- Lack of promotion of urinary bladder carcinogenesis by sodium bicarbonate and/or L-ascorbic acid in male ODS/Shi-od/od rats synthesizing alpha 2 mu-globulin but not L-ascorbic acid. (1997) (6)
- Possible Involvement of Adaptation Mechanisms in the Achievement of an Ineffective Dose Range for the Carcinogenicity of Genotoxic Carcinogens (2008) (6)
- Absence of promoting potential of bracken fern (Pteridium aquilinum) in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and uracil. (1995) (6)
- Induction of cell proliferation in the rat liver by the short-term administration of ethyl tertiary-butyl ether (2015) (6)
- Vascular changes during rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. (1977) (6)
- MARKED EPITHELIAL HYPERPLASIA OF THE RAT GLANDULAR STOMACH INDUCED BY LONG‐TERM ADMINISTRATION OF IODOACETAMIDE (1985) (6)
- Production of reversible papillary proliferation of the urinary bladder in rats. (1977) (6)
- DNA synthesis and scanning electron microscopic lesions in renal pelvic epithelium of rats treated with bladder cancer promoters. (1991) (6)
- Use of electroporation to accelerate the skin permeability enhancing action of oleic acid. (2000) (6)
- Lack of Promotion Effects of Sodium L-Ascorbate on Urinary Bladder Carcinogenesis in NCI-Black-Reiter (NBR) Male Rats Initiated with N-Butyl-N-(4-Hydroxybutyl) Nitrosamine (1997) (6)
- Genotoxicity of dimethylarsinous acid: high induction of tetraploids (2005) (6)
- Effects of uracil calculi on cell growth and apoptosis in the BBN-initiated Wistar rat urinary bladder mucosa. (1999) (6)
- Carcinogenicity study of methyl hesperidin in B6C3F1 mice. (1990) (6)
- Low-dose-dependent carcinogenic potential of 2-amino-3-methylimidazo[4,5-f]quinoline in the immunodeficient (SCID) mouse colon. (1999) (6)
- GRAS 29 flavoring substances (2020) (6)
- Bladder Cancers. Their Process of Development and Its Modification (1989) (6)
- Carcinogenicity of quinoline by drinking-water administration in rats and mice. (2018) (6)
- Re‐elevation of serum amlodipine level after lipid emulsion therapy in an overdose case (2019) (6)
- Review article Alterations in cyclin D1, p53, and the cell cycle related elements Implications for distinct genetic pathways of urinary bladder carcinogenesis. (1998) (6)
- [Animal models of bladder cancer]. (1988) (6)
- Nonenzymatic and Enzymatic Hydrolysis of 5-Fluoro-2′-deoxyuridine (FUdR) Esters (1988) (6)
- A new chemoembolization therapy for unresectable hepatocellular carcinoma using Aclarubicin microspheres in combination with Cisplatin suspended in lipiodol (1992) (6)
- Modification by alpha-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. (1987) (6)
- The Involvement of Pregnane X Receptor-regulated Pathways in the Antitumor Activity of Cisplatin (2019) (6)
- Modifying influence of prior treatment with toxic agents on induction of preneoplastic and neoplastic lesions in a medium-term multi-organ carcinogenesis bioassay. (1993) (6)
- Correspondence re: W. Paile's letter to the editor. Cancer Res., 60: 1146, 2000. (2001) (6)
- Quantitative evaluation of local pulmonary distribution of TiO2 in rats following single or multiple intratracheal administrations of TiO2 nanoparticles using X‐ray fluorescence microscopy (2016) (6)
- In vitro cytotoxicity of cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)] platinum(II) suspended in lipiodol in rat hepatoma AH-109A cells and human tumor cell lines. (2000) (6)
- Inhalation exposure to 1,2-dichloropropane: Distribution of blood and tissue concentrations of 1,2-dichloropropane in rats during and after exposure (2014) (6)
- Distribution of blood and tissue concentrations in rats by inhalation exposure to 1,2-dichloroethane (2013) (6)
- Induction of hepatocellular carcinoma with high metastatic potential in WS/Shi rats: discovery of an inbred strain highly susceptible to the liver carcinogen N-nitrosomorpholine. (2001) (6)
- Hepatocarcinogenic activity of N-butyl-N-(4-hydroxybutyl)nitrosamine in rats is not modified by sodium L-ascorbate. (1999) (6)
- Experimental study of hepatic artery administration of various formulations of lipiodol with anticancer agents (1987) (6)
- Dose response of N-butyl-N-(4-hydroxybutyl)nitrosamine on urinary bladder carcinogenesis in mutant ODS rats lacking L-ascorbic acid synthesizing ability. (1990) (6)
- New cyclic somatostatin analogues containing a pyrazinone ring: importance of Tyr for antiproliferative activity. (2008) (6)
- Promoting effects of unilateral ureteric ligation on two-stage urinary bladder carcinogenesis in rats. (1984) (6)
- Induction of preneoplastic and neoplastic lesions in rats treated N-nitroso compounds. (1982) (5)
- Sensitive quantitative assay for point mutations in the rat H-ras gene based on single nucleotide primer extension. (2010) (5)
- The inhalation exposure of carbon tetrachloride promote rat liver carcinogenesis in a medium-term liver bioassay. (2008) (5)
- Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells (2016) (5)
- Aberrant colonic epithelium in the bladder: report of a case. (1986) (5)
- Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N‐butyl‐N‐(4‐hydroxybutyl)‐nitrosamine (2003) (5)
- Cisplatin-loaded, Sialyl Lewis X-Modified Liposomes: Drug Release, Biodistribution and Antitumor Efficacy. (2017) (5)
- Serum concentration of the CKD4/6 inhibitor abemaciclib, but not of creatinine, strongly predicts hematological adverse events in patients with breast cancer: a preliminary report (2020) (5)
- Enhancing effect of diethylstilbestrol on urinary bladder carcinogenesis in neonatally castrated male rats. (1982) (5)
- Induction of tumors in the liver, urinary bladder, esophagus and forestomach by short-term treatment with different doses of N,N'-dibutylnitrosamine in rats. (1987) (5)
- Appropriate models and an understanding of carcinogenic mechanisms--requirements for hazard risk assessment. (2003) (5)
- Inhalation carcinogenicity of dichloromethane in rats and mice (2014) (5)
- Analysis of gene expression in different stages of MeIQx-induced rat hepatocarcinogenesis. (2007) (5)
- Studies on 2',3'-dideoxy-2',3'-didehydropyrimidine nucleosides. II. N4-benzoyl-2',3'-dideoxy-2',3'-didehydrocytidine as a prodrug of 2',3'-dideoxy-2',3'-didehydrocytidine (DDCN). (1989) (5)
- [Intra-hepatic artery infusional chemotherapy with cisplatin suspension in lipiodol (LPS) of hepatocellular carcinoma (I)--Preparation of LPS and its anticancer effect on a rabbit liver cancer model after injection into the hepatic artery]. (1988) (5)
- Examination of the Rat Model of Liver Injury via Thioacetamide (TAA) or Carbon Tetrachloride (CCl4) (2004) (5)
- Effect of H. pylori on COX-2 expression in gastric remnant after distal gastrectomy. (2004) (5)
- Local control of prostate cancer by intraarterial infusion chemotherapy facilitated by the use of angiotensin II. (1992) (5)
- Pharmacokinetic analysis for model‐supported therapeutic drug monitoring of busulfan in Japanese pediatric hematopoietic stem cell transplantation recipients (2020) (5)
- Changes in the Expression of Various Transporters as Influencing Factors of Resistance to Cisplatin. (2017) (5)
- Δ7-Prostaglandin C1: A primary metabolite of antitumor Δ7-prostaglandin A1 in the sera (1997) (5)
- Loss of Heterozygosity in (Lewis×F344)F1 Rat Urinary Bladder Tumors Induced with N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine Followed by Dimethylarsinic Acid or Sodium L‐Ascorbate (1999) (5)
- Altered Gene Expression in Rat Colonic Adenocarcinomas Induced in an Azoxymethane plus 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]- Pyridine Initiation-Promotion Model (2008) (5)
- Selective Induction of Prostate Carcinomas in F344 Rats Treated with Intraperitoneal Injections of N‐Hydroxy‐3,2′‐dimethyl‐4‐aminobiphenyl (1990) (5)
- FINE STRUCTURE AND LOCALIZATION OF PEROXIDASE ACTIVITY IN AMINOTRIAZOLE GOITER (1973) (5)
- 2nd International Symposium on Genotoxic and Carcinogenic Thresholds (2008) (5)
- Subchronic toxicity study of sodium o-phenylphenate in mice. (1985) (5)
- LACK OF MODIFICATION BY DIETARY UNSATURATED FAT OF 3, 2'-DIMETHYL-4-AMINOBIPHENYL-INDUCED RAT PROSTATE AND COLON CARCINOGENESIS (1989) (5)
- Promotion of liver and kidney carcinogenesis by ethyl tertiary-butyl ether (ETBE) in male Wistar rats. (2015) (5)
- Induction of hyperplastic liver nodules by phenobarbital in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine. (1980) (5)
- Angiographic Evaluation of Vascular Damage in Rat Liver After Administration of Epirubicin or Miriplatin. (2018) (4)
- Di-n-butyl Phthalate is Toxic to the Male Reproductive System and Its Toxicity is Enhanced by Thioacetamide Induced Liver Injury (2004) (4)
- Modulation of the pharmacokinetics of 5'-deoxy-5-fluorouridine and 5-fluorouracil in rats by oral co-administration of acyclothymidine. (1996) (4)
- [Modifying effects of beraprost sodium (TRK-100) on N-methyl-N-nitrosourea (MNU) carcinogenesis in F344 rats]. (1989) (4)
- Significance of L-ascorbic acid and urinary electrolytes in promotion of rat bladder carcinogenesis. (1985) (4)
- Revised rat multi-organ carcinogenesis bioassay for whole-body detection of chemopreventive agents: modifying potential of S-methylcysteine. (2004) (4)
- Assessment of cell cycle-related elements p53, p21WAF1/Cip1, cyclin D1 and PCNA in a mixed transitional cell carcinoma and adenocarcinoma of the renal pelvis: a case report. (1998) (4)
- Infrequent involvement of microsatellite instability in urinary bladder carcinomas of the NON/Shi mouse treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. (1998) (4)
- Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma. (1989) (4)
- Prevention of Urinary Bladder Cancer: The Interface Between Experimental and Human Studies. (2000) (4)
- Elevation of urinary enzyme levels in rat bladder carcinogenesis. (1999) (4)
- Methylation-associated silencing of four genes in human pancreatic cancers (2004) (4)
- Characteristic Upregulation of Glucose-Regulated Protein 78 in an Early Lesion Negative for Hitherto Established Cytochemical Markers in Rat Hepatocarcinogenesis (2009) (4)
- Osimertinib in a patient with non-small cell lung cancer and renal failure undergoing hemodialysis: a case report (2019) (4)
- Analysis of the Effects of Modifying Agents on Six Different Phenotypes in Preneoplastic Foci in the Liver in Medium-Term Bioassay Model in Rats (1988) (4)
- Altered expression of MRP2, MRP3 and UGT2B1 in the liver affects the disposition of morphine and its glucuronide conjugate in a rat model of cholestasis. (2009) (4)
- SIGNIFICANT INDUCTION OF EPITHELIAL CELL PROLIFERATION IN THE URINARY BLADDERS OF NCI-BLACK-REITER MALE RATS BY N-BUTYL-N-(4-HYDROXYBUTYL) NITROSAMINE (1995) (4)
- Differences in susceptibility to N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine‐induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis (2005) (4)
- Inhalation carcinogenicity of 1,1,1-trichloroethane in rats and mice (2013) (4)
- Promotion of chemically induced rat esophageal tumorigenesis with post-initiation ethanol modification. (2001) (4)
- Involucrin expression in urinary bladder carcinoma (2004) (4)
- Oral Carcinogenicity and Toxicity of 2‐Amino‐4‐chlorophenol in Rats (2009) (4)
- Standardization of Intratracheal Instillation Study of Manufactured Nanomaterials (2019) (4)
- Preparation and evaluation of two formulations: Cisplatin suspension in Lipiodol and polylactic acid microspheres containing aclarubicin hydrochloride: For intrahepatic arterial administration therapy for hepatocellular carcinoma (1992) (4)
- COMPARISON OF IMMUNOHISTOCHEMICAL DEMONSTRATION OF GLUTATHIONE-S-TRANS-FERASE PLACENTAL FORM (GST-P) AND HISTOCHEMICAL DEMONSTRATION OF γ-GLUTAMYL-TRANSPEPTIDASE (γ-GT) IN LIVER PRENEOPLASTIC LESIONS (1984) (3)
- Primary Carcinomas of Urinary Bladder Diverticula (1984) (3)
- Estimation of chloroform inhalation dose by other routes based on the relationship of area under the blood concentration-time curve (AUC)-inhalation dose to chloroform distribution in the blood of rats (2014) (3)
- Inhibition of 5'-deoxy-5-fluorouridine phosphorolysis by acyclopyrimidinenucleosides in intestinal tissue homogenates. (1995) (3)
- Lack of Hepatocarcinogenicity of Combinations of Low Doses of 2-amino-3, 8-dimethylimidazo[4,5- f ]quinoxaline and Diethylnitrosamine in Rats: Indication for the Existence of a Threshold for Genotoxic Carcinogens (2012) (3)
- Immunohistochemical distribution of epithelial membrane antigen in bladder carcinomas as detected with a monoclonal antibody (2004) (3)
- SEQUENTIAL MORPHOLOGICAL CHANGES OF ULCERATION IN THE GLANDULAR STOMACH OF RATS INDUCED BY IODOACETAMIDE (1975) (3)
- P02: Carcinogenicity and in vivo mutagenicity of 1,4-dioxane in gpt delta rats (2009) (3)
- Neovascularization in the Development of Epithelial Proliferative Lesions of the Rat Urinary Bladder: A Light Microscopic, Immunohistochemical and Ultrastructural Study (1997) (3)
- [A case of synchronous triple primary cancers of prostate, kidney and bladder]. (1998) (3)
- Alterations of Cell Cycle Regulators in Rat and Mouse Urinary Bladder Carcinogenesis Models (1997) (3)
- Suppressive effect of CPT-11 on rat esophageal tumorigenesis induced by N-nitrosomethylbenzylamine. (2004) (3)
- Threshold for Genotoxic Carcinogens: The Central Concern in Carcinogenic Risk Assessment (2012) (3)
- Lack of Promoting Potential of Dimethylarsinic Acid in the Kidney of Male NCI-Black Reiter Rats (2000) (3)
- Pharmacokinetics of Ephedrine and Pseudoephedrine after Oral Administration of Kakkonto to Healthy Male Volunteers (2009) (3)
- Effect of duodenogastric reflux on N-methyl-N'-nitro-N-nitrosoguanidine-induced glandular stomach tumorigenesis in Helicobacter pylori-infected Mongolian gerbils. (2004) (3)
- Lack of Inhibitory Effects of Coumaperine from Pepper on the Promotion Stage of Chemical Hepatocarcinogenesis in the Rat (2003) (3)
- Lack of micronucleus induction activity of ethyl tertiary-butyl ether in the bone marrow of F344 rats by sub-chronic drinking-water treatment, inhalation exposure, or acute intraperitoneal injection. (2013) (3)
- 2,4-Dichloro-1-nitrobenzene exerts carcinogenicities in both rats and mice by two years feeding (2012) (3)
- Low Susceptibility of Nude Mice to Induction of Invasive Urinary Bladder Cancers by N-Ethyl-N-(4-hydroxybutyl)nitrosamine (1992) (3)
- Membrane potential of rat urinary bladder epithelial cells. (1983) (3)
- Maternal-to-Fetal Transfer of Ritodrine in Twin Pregnancy (2012) (3)
- Carcinogenic risk assessment: are there dose thresholds for carcinogens? (2010) (3)
- Expression and Localization of Ornithine Decarboxylase in Reversible Papillomatosis Induced by Uracil in Rat Bladder (1998) (3)
- Biochemical study of pyloric metaplasia in the mucosa regenerating over iodoacetamide-induced fundic ulcers in rat stomach. (1976) (3)
- Spontaneous Harderian Gland Adenocarcinoma in a Female F344 Rat: A Case Report (2014) (2)
- IMPROVEMENT OF HAMSTER-LUNG FIBROSIS MODEL BY REPEATED INTRATRACHEAL ADMINISTRATION OF BLEOMYCIN (1996) (2)
- DETECTION OF BLADDER CANCER WITH NARROW-BAND IMAGING SYSTEM (2009) (2)
- Molecular cytogenetic identification of cyclin D1 gene amplification in a renal pelvic tumor attributed to phenacetin abuse (1999) (2)
- PROTECTIVE EFFECTS OF BUTYLATED HYDROXYANISOLE AGAINST BLEOMYCIN-INDUCED DIFFUSE ALVEOLAR DAMAGE IN HAMSTERS (1995) (2)
- A simplified method for therapeutic drug monitoring of mitotane by gas chromatography‐electron ionization‐mass spectrometry (2019) (2)
- Elevation in putrescine level and spermidine/spermine N1-acetyltransferase activity coincide with tumor development in 1, 2-dimethylhydrazine-induced rat colon. (1998) (2)
- Immunohistochemically demonstrated variation in expression of cathepsin E between uracil-induced papillomatosis and N-butyl-N-(4-hydroxybutyl)nitrosamine-induced preneoplastic and neoplastic changes in rat urinary bladder (1996) (2)
- Absence of β-catenin Mutations in Mouse Hepatoblastomas Induced by N, N-dimethylformamide (2004) (2)
- HISTOPATHOLOGICAL FINDINGS OF THE URINARY BLADDER EPITHELIUM IN AGED DOGS (1994) (2)
- Lack of Tumorigenic Effects on Rat Renal Pelvic Transitional Epithelium of Life-Span Exposure to Low Doses of a Bladder Carcinogen (1993) (2)
- INDUCTION OF PRENEOPLASTIC LESIONS BY SEQUENTIAL TREATMENT OF RATS WITH THREE CARCINOGENS: N-BUTYL-N-(4-HYDROXYBUTYL) NITROSAMINE, 7, 12-DIMETHYLBENZ(a)-ANTHRACENE, AND N-METHYL-N-NITRO-N-NITROSOGUANIDINE (1991) (2)
- Validation of a novel sensitive method for measuring maternal and neonatal serum ritodrine concentrations (2013) (2)
- Carcinogenic Potential of 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) in Severe Combined Immunodeficient (SCID) Mice (2004) (2)
- 13-week subchronic toxicity study with morpholine oleic acid salt administered to B6C3F1 mice. (1987) (2)
- Differences of Promoting Activity and Loss of Heterozygosity Between Dimethylarsinic Acid and Sodium L-ascorbate in F1 Rat Urinary Bladder Carcinogenesis (1999) (2)
- MODULATION OF N-BUTYL-N-(4-HYDROXYBUTYL) NITROSAMINE-INDUCED RAT URINARY BLADDER CARCINOGENESIS BY POST-TREATMENT WITH COMBINATIONS OF THREE PHENOLIC ANTIOXIDANTS (1989) (2)
- The enhancing effect of ethanol on the mutagenic activation of N-nitrosomethylbenzylamine by cytochrome P450 2A in the rat oesophagus. (2013) (2)
- Possible involvement of O6-methylguanine formation and p53 dysfunction in mouse urinary bladder carcinogenesis. (2001) (2)
- A study of antitumor effects of thymosin on rat and mouse urinary bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine. (1996) (2)
- Threshold in Carcinogenicity of Genotoxic Carcinogens (2014) (2)
- A Simple Method for the Preparation of Cells from Rat Urinary Bladder Epithelium for Flow Cytometry (1997) (2)
- Possible prevention by abieslactone of development of diethylnitrosamine-initiated GST-P positive foci in the rat liver. (2001) (2)
- [Intra-hepatic artery infusional chemotherapy with cisplatin suspension in lipiodol (LPS) of hepatocellular carcinoma (II)--A clinical study]. (1988) (2)
- Immunohistochemical observations of keratins, involucrin, and epithelial membrane antigen in urinary bladder carcinomas from patients infected withSchistosoma haematobium (2004) (2)
- Low Tumorigenic Response to 3,2′‐Dimethyl‐4‐aminobiphenyl Administration in the Prostate of Rats Castrated at Birth (1988) (2)
- Lack of Urinary Bladder Carcinogenicity of Sodium L-Ascorbate in Human c-Ha-ras Proto-Oncogene Transgenic Rats (2005) (2)
- [Pharmaceutical and pharmacological development of antitumor prostaglandins]. (1998) (2)
- Thinking on occupational exposure assessment of multi‐walled carbon nanotube carcinogenicity (2019) (2)
- Effect of partial cystectomy on the induction of pre-neoplastic lesions in rat bladder initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by bladder carcinogens and promoters (2004) (2)
- Difference in Ritodrine Pharmacokinetics between Singleton and Twin Pregnancies (2013) (2)
- Papilloma, Forestomach, Rat (1997) (2)
- Medium-term Tests for Carcinogens and Carcinogenic Hazard Evaluation for Humans (2008) (2)
- Inhibition of azoxymethane-induced colon carcinogenesis in rats due to JTE-522, a selective cyclooxygenase-2 inhibitor. (2004) (2)
- Identification of an N-acetylcysteine conjugate in the urine after oral administration of 2,4-dichloro-1-nitrobenzene to rats. (2009) (2)
- ENHANCING EFFECTS OF CARCINOGENS OR PROMOTERS ON BLADDER CARCINOGENESIS IN RATS (1991) (2)
- Promotion of liver and kidney carcinogenesis by ethyl tertiary-butyl ether (ETBE) in male Wistar rats (2015) (2)
- Comparison of Pregnane X Receptor Antagonists for Enhancing the Antitumor Effect of Cisplatin (2019) (2)
- Post-initiation inhibition of MeIQx hepatocarcinogenesis in rats by cysteine. (2003) (2)
- Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice. (2004) (2)
- Disposition of enantiomers of sultopride in a human, rats and rabbits. (1993) (2)
- [Basic studies on optimal intra-arterial infusion rate of cisplatin]. (1989) (1)
- Susceptibility of Male WS/Shi Rats to Melamine but not NaHCO3 or Butylated Hydroxyanisole Promotion of Urinary Bladder Carcinogenesis (2000) (1)
- Effect of cyclophosphamide on rat urinary bladder epithelium treated wtih N-butyl-N-(4-hydroxybutyl)nitrosamine. (1980) (1)
- THE COMBINED EFFECTS OF N-METHYL-N'-NITRO-N-NITROSOGUANIDINE AND 20-METHYLCHOLANTHRENE ASSOCIATED WITH SURFACTANTS ON THE INDUCTION OF CANCER OF THE GLANDULAR STOMACH IN RATS (1973) (1)
- Lack of Inhibition of BBN-induced Bladder Carcinogenesis in C57BL/6 Mice by Intravesical Instillation of KRN 7000 (2003) (1)
- Hydrolysis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) in rabbit and human plasma and its release from oily solution. (1989) (1)
- Plasma concentration of amitriptyline and metabolites after resuscitation from cardiopulmonary arrest following an overdose: A case report (2020) (1)
- Effect of iodoacetamide or Tween 60 on methylnitrosocyanamide carcinogenesis in rat glandular and forestomach. (1977) (1)
- PREPARATION AND EVALUATION OF W/O TYPE AND W/O/W TYPE EMULSIONS CONTAINING AN ANTICANCER DRUG (1986) (1)
- Ethanol Does Not Promote MeIQx-initiated Rat Colon Carcinogenesis Based on Evidence from Analysis of a Colon Cancer Surrogate Marker (2009) (1)
- 451PD Osimertinib at 80 mg for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer (2016) (1)
- Lack of inhibitory effects of the Ju-myo protein on development of glutathione S-transferase placental form-positive foci in the male F344 rat liver. (1999) (1)
- HISTOCHEMICAL OBSERVATION OF LECTIN-BINDING PATTERNS IN PAGET'S DISEASE (1986) (1)
- Effects of cessation of alcohol exposure on rat hepatocarcinogenesis. (2006) (1)
- Possible inhibitory effects of promotion stage treatment with thymosin fraction 5 on N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary tract carcinogenesis in NON/Shi mice. (1996) (1)
- Jun Shen (2004) (1)
- RESPONSE OF URINARY CONSTITUENTS AND BLADDER EPITHELIUM TO ADMINISTRATION OF CHEMICALS AND THEIR SODIUM SALTS POSSESSING PROMOTING POTENTIAL SODIUM SALTS (1985) (1)
- Evaluation of the fluorescence polarization immunoassay method for determination of serum mexiletine concentrations. (1989) (1)
- Inhibiting effects of diethylmaleate or NH4Cl on NaHCO3, but not butylated hydroxyanisole, promotion of urinary bladder carcinogenesis in male F344 rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. (1994) (1)
- Quantitative analysis of mutagenicity and carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in F344 gpt delta transgenic rats. (2019) (1)
- An autopsy report of graft-versus-host disease (GVHD) following blood transfusion. (1999) (1)
- Evaluation of a new lipophilic prodrug 3', 5'-dioctanoyl-5-bromodeoxyuridine (BrdU-C8) suspended in Lipiodol as a radiosensitizer for the treatment of AH136B tumor. (1993) (1)
- Distribution of 1,2-dichloropropane in blood and other tissues of rats after oral administration. (2017) (1)
- [Limited application of the three drug-mixed anesthesia for bronchoalveolar lavage fluid sampling]. (2016) (1)
- Imexon and gemcitabine are synergistic against human pancreatic cancer cells in vitro and in vivo (2005) (1)
- Chapter 8: MODIFICATION OF CARCINOGENESIS BY ANTIOXIDANTS AND OTHER COMPOUNDS (2009) (1)
- [Development of invasive urinary bladder carcinomas]. (2006) (1)
- [Intra-arterial injection of cisplatin suspension in Lipiodol (LPS) in the treatment of hepatocellular carcinoma]. (1989) (1)
- No inhibition of urinary bladder carcinogenesis in rats with intravesical instillation of alpha-galactosylceramide. (2003) (1)
- Absence of β-Catenin Alteration in Hepatic Tumors Induced by p-Nitroanisole in Crj:BDF1 Mice (2006) (1)
- GRAS 27 flavoring substances (2015) (1)
- Promoting Effect of Sodium L-Ascorbate on N-Butyl-N-(4-hydroxybutyl)nitrosamine-induced Renal Pelvic Carcinogenesis in SD/cShi Rats of Both Sexes (2003) (1)
- Effect of phenacetin pretreatment on renal pelvic carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice of both sexes. (1994) (1)
- Alpha2u-Globulin Nephropathy in Rats Treated with a Glycosaminoglycan Extracted from Sea Cucumber (2001) (1)
- Lack of modification of rat hepatocarcinogenesis by fernane-type triterpenoids, isolated from a Euphorbia genus. (2002) (1)
- Effects of intravesical instillation of antitumor drugs on the induction of preneoplastic bladder lesions in rats (2004) (1)
- Drug Interaction between Diltiazem and Aprindine. II (1998) (1)
- Analysis of the Effects of Modifying Agents on Proliferation and Enzyme Phenotype in Focal Preneoplastic and Neoplastic Liver Lesions in Rats (1991) (1)
- Differential effects of acyclothymidine, a potent pyrimidine nucleoside phosphorylase inhibitor, on the pharmacokinetics of doxifluridine in rabbits via oral administration. (1993) (1)
- Chapter 16 – Carcinogenicity of dimethylarsinic acid and relevant mechanisms (2003) (1)
- Pharmacokinetics and clinical outcomes of nivolumab administered every 4 weeks in patients with advanced non-small-cell lung cancer: A four-case pilot study. (2021) (1)
- Biphasic effect of alpha benzene hexachloride (α-BHC) on diethylnitrosamine-intiated hepatocarcinogenesis and possible hormesis mechanism in rats. (2005) (1)
- PROMOTING EFFECTS OF SODIUM L-ASCORBATE ON RAT BLADDER CARCINOGENESIS (1982) (0)
- P03: A novel marker, alpha2-macroglobulin and GRP78, characteristic of rat hepatocellular preneoplastic and neoplastic lesions undetectable by Glutathione S-transferase placental form (2009) (0)
- The Considerable Effects on Anti-tumor Activity and Cell Permeability of Small Peptides Containing Adamantyl Group (2011) (0)
- Induced by Uracil-Calculi and Subsequent Development of Reversible Papillomatosis in the Rat Urinary Bladder 1 (2006) (0)
- HISTOLOGICAL SEQUENCE OF REGENERATION ON THE HETEROTOPICALLY TRANSPLANTED RAT BLADDER (1995) (0)
- Petroselinic Acid and Oleic Acid : Comparison of Enhanced Skin Permeability Relative to Affinity for Saturated Fatty Acids of Stratum Corneum (2000) (0)
- Evaluation of five sustained release preparations of isosorbide dinitrate. (1989) (0)
- Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory. Nara Uro-oncology Research Group. (NUORG). (1994) (0)
- Δ7-Prostaglandin C1: A Primary Metabolite of Antitumor Δ7-Prostaglandin A1 in the Sera. (1998) (0)
- Carcinogenicity of ortho-phenylenediamine dihydrochloride in rats and mice by two-year drinking water treatment (2012) (0)
- [GANN, 64, 211-218; June, 1973] UDC 616-006-021.6[616.33]:615.277.4 CARCINOGENIC EFFECT OF N-METHYL-N'-NITRO-N- NITROSOGUANIDINE WITH VARIOUS KINDS OF SURFACTANT IN THE GLANDULAR STOMACH OF RATS*1 (2008) (0)
- Release characteristics of a free polyunsaturated fatty acid from an oily lymphographic agent. (1990) (0)
- Bladder Cancer: Detection and Screening (2009) (0)
- An Autopsy Case of Bullous Pemphigoid with Hypersensitivity Pneumonitis (1994) (0)
- Induction of DNA‐adducts and increase of 8‐hydroxy‐2‐deoxyguanosine, but no development of preneoplastic lesions in offspring liver with transplacental and trans‐breast milk exposure to 2‐amino‐3,8‐dimethylimidazo [4,5‐f]quinoxaline (MelQx) in rats (2004) (0)
- Abstract 680: Antitumor activity of CDDP and nuclear receptor PXR (2011) (0)
- S4-5 Analysis of Arsenic Carcinogenicity : Using Animal Models(SYMPOSIUM 4: ARSENIC IN THE ENVIRONMENT AND THE TOXICITY)(Proceedings of the 31st Annual Meeting) (2004) (0)
- Effects of delta(7)-prostaglandin a(1) methyl-ester on human ovarian-cancer cell-growth in-vitro and in nude-mice. (1994) (0)
- Title : In vitro chromosomal aberrations induced by various shapes of multi-walled carbon 3 nanotubes ( MWCNTs ) 4 Name of each author : (2016) (0)
- Variation and Location of Cytochrome P450 Isoenzymes in Various Organs Including the Liver of Rats Treated with Methylbenzylnitrosamine, N, N-dibutylnitrosamine, and 1, 2-Dimethylhydrazine (1997) (0)
- Fibrous Hamartoma in Infancy : A Case Report (1990) (0)
- Evaluation of three novel pyrazole-bridged dinuclear platinum (II) complexes (2008) (0)
- 2,4-Dichloro-1-nitrobenzene exerts carcinogenicities in both rats and mice by two years feeding (2012) (0)
- Immunohistochemically Detected O 6-and N 7-Methyldeoxyguanosine in Organs of Rats Administrated N-Methyl-N-Nitrosourea (2008) (0)
- Morphological Changes in Silver-stained Nucleolar Organizer Regions (AgNORs) Related to Proliferative Activity in Glutathione S-transferase Placental Form (GST-P) Positive Foci of Rat Liver (2000) (0)
- Differentially expressed genes in the livers of rats treated with DEN and administered Valerian at doses of 50, 500 and 5000 ppm, identified by Affimetrix microarray analysis. (2014) (0)
- Immunohistochemical identification of keratin, involucrin, and epithelial membrane antigen in Paget's disease (1988) (0)
- Lack of Inhibitory Effects of an Anti-angiogenesis Drug, TNP-470, on Rat Urinary Bladder Papillomatosis Induced by Mechanical Stimulation (2002) (0)
- Hormesis in Chemical Carcinogenesis Threshold in Carcinogenicity of Environmental Carcinogens (2006) (0)
- Dimethyl-4-aminobiphenyl ′ of Administration of 3 , 2 Organs of the Rat in Response to Varied Dosage and Duration Variation in Tumor Yield in the Prostate and Other Target (2006) (0)
- Differences in Sensitivity of F344 Rats from Different Breeders to Phenobarbital Hepatocarcinogenicity (2006) (0)
- MP-12.05 (2006) (0)
- “Chernobyl cystitis” induced by chronic low dose ionizing radiation effect through oxidative stress (2003) (0)
- Effects of streptozotocin dosing on the disease state of streptozotocin-induced diabetic rats (2011) (0)
- P081 Chemopreventive effects of Tamarind (Tamarindus indica L) husk extract on the early stages of rat hepatocarcinogenesis (2007) (0)
- Occurrence of two different types of glutathione S-transferase placental form-positive hepatocytes after a single administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in rats. (2008) (0)
- [Characteristics of early carcinomas and precancerous lesions in the urinary bladder]. (1995) (0)
- Abstract 840: Enhancement of antitumor effect of platinum complexes by PXR antagonist (2014) (0)
- A Case of Malignant Rhabdoid Tumor of the Kidney (1993) (0)
- High Susceptibility of p 53 ( + / †” ) Knockout Mice in W-Butyl-W-( 4-hydroxybutyl ) nitrosamine Urinary Bladder Carcinogenesis and Lack of Frequent Mutation in Residual AlÃ-ele 1 (2006) (0)
- Are there thresholds for carcinogens carcinogenicity (2008) (0)
- MP-04.01: Molecular mechanisms of the urinary bladder carcinogenesis (the intercellular proteolysis alteration) influenced by persistent, long-term, low-dose ionizing radiation in humans (2007) (0)
- Abstract 4742: Comparison of enhancement of the antitumor effect of CDDP by PXR antagonists (2016) (0)
- Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory (2004) (0)
- The Antiproliferative Activities of Somatostatin Analogs on Various Tumor Cells (2006) (0)
- 16th Japanese Pathology for Carcinogenesis Meeting (Hatsugan-Byori Kenkyukai). (2001) (0)
- Amplifying Effects of Uracil on Multi-Stage Bladder Carcinogenesis in Rats (1991) (0)
- Analysis of correlation between weekly average darbepoetin alfa dose and hemoglobin levels in patients undergoing peritoneal dialysis (2013) (0)
- DOSE-RESPONSE STUDY ON EARLY LESIONS AND CARCINOGENESIS OF RAT URINARY BLADDER INDUCED BY N-BUTYL-N-(4-HYDROXYBUTYL)-NITROSAMINE (1988) (0)
- RELIABILITY AND PRACTICALITY OF MEDIUM-TERM CARCINOGENESIS BIOASSAYS(WORKSHOP 4 : NEW TECHNOLOGY AND EVALUATIONS OF IN VIVO TOXICITY STUDIES) (2002) (0)
- and Sustained Release of Its Active Metabolites in VX-2 Rabbit Hepatoma followingIntraarterial Administration of FdUrd-C8 Solution in Lipiodol (1988) (0)
- Biphasic Increase of Epithelial DNA Synthesis in the Urinary Bladder of Rats Treated with a Tumor Promoter, Sodium L-ascorbate (2006) (0)
- RELEVANCE OF URINARY Na^+ AND pH TO TUMOR DEVELOPMENT IN 2-STAGE RAT URINARY BLADDER CARCINOGENESIS (1987) (0)
- The Journal of Toxicological Sciences (2003) (0)
- EFFECTS OF MONOSODIUM SUCCINATE, DISODIUM SUCCINATE, AND SUCCINIC ACID ON URINARY BLADDER CARCINOGENESIS IN N-BUTYL-N-(4-HYDROXYBUTYL)-NITROSAMINE-INITIATED, UNILATERALLY URETER-LIGATED RATS (1990) (0)
- Hepatotumorigenicity of ethyl tertiary-butyl ether with 2-year inhalation exposure in F344 rats (2013) (0)
- Nobuyuki Ito, MD, PhD (2011) (0)
- A18 RAT WIDE-SPECTRUM INITIATION MULTIPLE ORGAN BIOASSAY MODELS FOR ASSESSING MODIFYING EFFECTS IN CARCINOGENESIS (1989) (0)
- Drug Interaction between Diltiazem and Aprindine. II : Involvement of Human Liver Microsomes (2010) (0)
- Enhancement of Propylene Glycol Permeation into Rat Dermis Using High-purity Oleic Acid and Subsequent Alteration of the Dermal Protein Structures (1997) (0)
- Lack of Enhanced Epithelial Cell Proliferation in the Urinary Bladder of Heterozygous p53 Knockout Mice Given Sodium Ortho-phenylphenate or Uracil (2003) (0)
- Effect of Magnesium Supplementation to Prevent Nephrotoxicity on the Antitumor Activity of Cisplatin (2019) (0)
- Tumours of the urinary bladder, renal pelvis, ureter and urethra. (1996) (0)
- Research of Pharmacokinetics for Rectal Suppositories of Trazodone in Healthy Volunteers (2018) (0)
- Acyclothymidine alleviates intestinal toxicity of 5'-deoxy-5-fluorouridine without loss of antitumor activity in mice. (1996) (0)
- Carcinogenic Risk of Environmental Carcinogens (2001) (0)
- L-Ascorbic Acid Amplification of Bladder Carcinogenesis Promotion by K2CO3l (2006) (0)
- P6-02 Enhancement of thioacetamide-induced liver cirrhosis by estradiol 3-benzoate in the rats(LIVER AND DIGESTIVE SYSTEM/CIRCULATORY SYSTEM-1/DEVELOPMENT AND REPRODUCTION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting) (2004) (0)
- Carcinogenidty of catechol in F344 rats and B6C3Fj mice (2005) (0)
- DETERMINATION OF THALIDOMIDE BLOOD CONCENTRATION IN PATIENTS BY LCMS (2009) (0)
- No Promoting Effect of Ethyl Tertiary-butyl Ether (ETBE) on Rat Urinary Bladder Carcinogenesis Initiated with N-Butyl-N-(4-hydroxybutyl)nitrosamine (2013) (0)
- WEAK SYNERGISTIC EFFECT OF URACIL AND N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE ON URINE COMPOSITION, EPITHELIAL MORPHOLOGY, AND DNA SYNTHESIS IN THE URINARY BLADDER OF SYRIAN GOLDEN HAMSTER (1995) (0)
- UP-3.002: Alteration of Ubiquitination and Sumoylation Processes in Urinary Bladder Carcinogenesis Induced by Persistent Long-Term Low Dose Ionizing Radiation in Humans (2009) (0)
- EFFECTS OF PARTIAL CYSTECTOMY, UNILATERAL URETERIC LIGATION, AND URETHRAL INJECTION OF PHYSIOLOGICAL SALINE ON URINARY BLADDER EPITHELIAL PROLIFERATION IN RATS (1988) (0)
- Inhibitory effect of phenobarbital at low dose on rat hepatocarcinogenesis : the evidence for hormesis (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting) (2003) (0)
- Irritative Effects of Drug Solutions on the Rectal Membranes (1984) (0)
- Application of lipiodol containing liposoluble platinum complexes to intra-arterial chemotherapy: Anticancer effect on rabbit liver cancer model. (1990) (0)
- Expression of 8-hydroxydeoxyguanosine in the gastric remnant after distal gastrectomy. (2008) (0)
- B-6 INHIBITORY EFFECT OF CHEMICALS ON THE DEVELOPMENT OF PRENEOPASTIC LIVER LESIONS IN RATS (1990) (0)
- Area under the blood concentration-time curve (AUC) of ethylbenzene concentration in rats: relationship to inhalation and oral administration route-dose (2020) (0)
- Vascular endothelial growth factor mRNA levels as a biomarker for short‐term N‐butyl‐N‐(4‐hydroxybutyl) nitrosamine‐induced rat bladder carcinogenesis bioassay (2015) (0)
- F344/Shi rats bearing type b catalase-1 locus are sensitive to sodium L-ascorbate promotion of two-stage urinary bladder carcinogenesis. (1998) (0)
- Inhibitory Effect of Vitamin E on Cellular Events Related to Lung Tumorigenesis in Mice (1997) (0)
- Use of Partially Nephrectomized Rats for Toxicity Studies : Comparison of Partially Nephrectomized Rats and Normal Rats (1998) (0)
- [Gann, 74, 21-27; February, 1983] DIFFERENT DOSE-RESPONSE RELATIONSHIPS IN THE INDUCTION OF DIFFERENT TYPES OF COLONIC TUMORS IN WISTAR RATS BY 1,2- DIMETHYLHYDRAZINE (2007) (0)
- Body, relative liver and kidney weights and AST and ALT levels in the blood serum of rats treated with DEN or vehicle (saline) and administered Valerian at doses of 50, 500 and 5000 ppm. (2014) (0)
- [Basic studies on the lipiodolization of miriplatin in combination with CDDP]. (2014) (0)
- [Histological classification of urinary bladder tumors]. (1982) (0)
- Immunohistochemically Detected O6-and N7-Methyldeoxyguanosine in Organs of Rats Administrated N-Methyl-N-Nitrosourea (1997) (0)
- Lung carcinogenicity of multi-walled carbon nanotube by inhalation exposure (2016) (0)
- CARCINOGENICITY OF DIFOLATAN IN B6C3F_1 MICE (1982) (0)
- Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy (2019) (0)
- Evaluation of Pediatric Doses in Therapeutic Drug Monitoring. (1991) (0)
- DELTA 7-PROSTAGLANDIN C1: A PRIMARY METABOLITE OF ANTITUMOR DELTA 7-PROSTAGLANDIN A1 IN THE SERA (1997) (0)
- [Improvement of the viscosity and the intrahepatic distribution of miriplatin-lipiodol suspension]. (2014) (0)
- Application of ISO 5725 to evaluate measurement precision of distribution within the lung after intratracheal administration (2018) (0)
- Multi‐organ carcinogenicity by inhalation exposure to 2‐Bromopropane in rats (2023) (0)
- Abstract 5837: Acquired resistance to anticancer drug of high glucose-exposed HepG2 (2018) (0)
- Aspirin Inhibition of A /-[ 4-( 5-Nitro-2-furyl )-2-thiazolyl ] formamide-induced Lesions of the Urinary Bladder Correlated with Inhibition of Metabolism by Bladder Prostaglandin Endoperoxide Synthetase 1 (2006) (0)
- Lack of Influence of Testicular Castration or Sialoadenectomy on Sodium L-Ascorbate Promotion of Urinary Bladder Carcinogenesis in Male F344 Rats (2003) (0)
- Histological and Mucin Histochemical Study of Colon Ulcers Induced in Rats by a Rapid Freezing Method (2004) (0)
- Numbers and areas of GST-P + foci in the livers of rats treated with DEN or vehicle and administered Valerian at doses of 50, 500 and 5000 ppm. (2014) (0)
- Abstract 5553: Low-dose carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in rats: Evidence for the existence of no-effect levels and a mechanism involving p21Cip/WAF1 (2011) (0)
- Influence of Strain and Diet on Hepatocarcinogenicity of N-Butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in Rats: Slight Inhibition of Preneoplastic Liver Lesion Development by Uracil (2005) (0)
- S1-4 Threshold of Environmental Carclnogens(SYMPOSIUM 1: ASSESSMENT OF LOW DOSE EFFECT AND THRESHOLD)(Proceedings of the 31st Annual Meeting) (2004) (0)
- Urinary bladder carcinogenesis in humans after the chernobyl accident in Ukraine (molecular mechanisms) (2002) (0)
- Chemoprevention of Rat Carcinogenesis by Water-soluble Organosulfur Compounds (2000) (0)
- Thresholds for Carcinogenicity of Environmental Carcinogens (SYMPOSIUM3: RECENT TOPICS ON THE RISK ASSESSMENT OF CHEMICAL CARCINOGENS) (Proceedings of the 30th Annual Meeting) (2003) (0)
- Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats (2015) (0)
- Significance of Cyclin D1 Overexpression in Transitional Cell Carcinomas of the Urinary Blad- der and its Correlation With Histopathologic Features C. C. R. LEE, S. YAMAMOTO, K. MORIMURA, H. WANIBUCHI, N. NISHISAKA, S. IKOMOTO, T. NAKATANI, S. WADA, T. (1997) (0)
- Antitumor effect, toxicity and pharmacokinetics of 13, 14-Dihydro15-deoxy-Δ7-PGA1 methyl ester (TEI-9826) integrated in lipid microsphere at continuous intra venous infusion in rat (1999) (0)
- In vivo positive mutagenicity of 1,4-dioxane and quantitative analysis of its mutagenicity and carcinogenicity in rats (2018) (0)
- Gene-modified embryonic stem cell test to characterize chemical risks (2015) (0)
- Asclepic Acid(cis-ω7-Octadecenoic Acid) as a Skin Penetration Enhancer : Its Behavior and Effects on Rat Stratum Corneum and Dermis (1999) (0)
- O-04 Chemopreventive effects of Tamarind (Tamarindus indica L) husk extract on the early stages of rat hepatocarcinogenesis(ACEM Oral Presentation I) (2007) (0)
- S1-4 Are there thresholds of genotoxic carcnogens? (2004) (0)
- odifying Factors in urinary Bla der Carcinogenesis (2016) (0)
- Development of Medium-Term Bioassays for Detection of Chemopreventive Agents (1997) (0)
- Reliability Evaluation of the Mediumterm Liver Bioassay Based on Long-term Feeding Study Results for Phenobarbital with Reference to the Dose-response (1998) (0)
- Enhancement of hepatocarcinogenicity by MeIQx in thioacetamide-treated liver (2005) (0)
- Development and validation of a method for epidermal growth factor receptor tyrosine kinase inhibitors quantification in dried blood spots: practices of pharmacist assisted self-blood sampling (2018) (0)
- Modulation of Cytochrome P 450 Expression by Kojic Acid in Rats (2015) (0)
- Atrophy of Rat Exorbital Lacrimal Glands Induced by Atropine (2000) (0)
- Evaluation of initiation activity of dimethylarsinic acid: Initiation potential of rat hepatocarcinogenesis (2009) (0)
- Susceptibility of Four F1 Hybrids of Male Rats to the Promoting Effects of Sodium L-ascorbate in Two-Stage Urinary Bladder Carcinogenesis (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Shoji Fukushima?
Shoji Fukushima is affiliated with the following schools:
